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Abstract
Sidketa Ida Fofana, Ph.D. The University of Memphis. August, 2019. Essays in
Applied Economics. Major Professor Joonhyung Lee, Ph.D.
My dissertation consists of two essays in applied Microeconomics. I study the main
determinants of Diabetes and breast cancer. My first essay is on diabetes, it assesses
racial differences and the impact of health care coverage in self-Care management
and quality of care for 9, 805 diabetes patients in Texas. Using a multiple logistic
regression model, I find that Hispanics with diabetes in Texas are still struggling to
improve their self-management and gain access to quality care compared to Black
and White non-Hispanics. For instance, 41.4% of Hispanics fail to perform daily
foot care compared to 34.2% of White non-Hispanic and 25% of Black
non-Hispanics. Furthermore, Hispanics are less likely to have a provider checking
their AIC (OR: 0.54, 95%, CI, .45-.63) and Black (OR: 0.87, CI 0.67-1.12) compared
to Whites. My results also indicate that having health care coverage and taking a
diabetes self-management class significantly improves self-management and
considerably reduces the race disparity On my second essay, I take advantage of this
20-year cohort study of cancer survival data in Texas to study the main factors that
can explain why some breast cancer patients live longer than others. Using a
survival analysis which consists of performing a log-rank test, a survival time
regression and a Cox proportional hazards regression, and dividing the data in
groups based on the survival time then running a multinomial logistic regression,
my results suggest that stage at diagnostic is the most important drivers of breast
cancer survival, in fact, compared to stage1 survivors, survivors with stage IV are
more likely to die with a hazard ratio of (14.02). I also find that being diagnosed
with advanced grade will lead to short survival time. Furthermore, there are some
racial disparities in survival time. Finally, I find that most of the disparities in
terms of stage, grade, age, race and income occur in the first five years of survival.
Those two essays lead to some policy recommendations such as facilitating access to
iii

quality of care for minorities in case of diabetes and promoting early breast cancer
screening and diagnostic in vulnerable communities.
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Chapter 1
Introduction
My dissertation is composed of two essays in applied Microeconomics more
precisely in health economics. According to Fuchs (2010), health economics is a
behavioral science and it also provides major insights for health policy issues and
health services research. In my research, I explore those two routes of the field. I
investigate positive issues using real life data to analyze behaviors and relations
within variables that affects conditions such as diabetes or breast cancer. I then
make useful recommendations for policy makers to improve the general well being of
economic agents, and increase their longevity.
My dissertation is centered on certain chronic diseases with high incidence on
the United State population. In fact, diabetes is a chronic disease that can lead to
serious complications if not properly taken care of. An estimate of 9.4% of the
United State (US) population (30.3 million people) had the disease in 2015,
according to the National Diabetes Statistics Report. Additionally, an estimate of
33.9% of the US adults aged 18 years or older (84.1 million people) had pre-diabetes
in 2015. Moreover, from a CDC report, breast cancer is the second most common
cancer after skin cancer among women in the United States across all races and
ethnicities. In fact, in 2014, 236, 968 women and 2, 141 men in the United States
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were diagnosed with breast cancer. Additionally, 41, 211 women and 465 men in the
United States died from it (CDC). In the U.S., one in eight women will be
diagnosed with invasive breast cancer during her lifetime according to National
Cancer Institute. Those two conditions are burdens to tax payers, they are public
health issue and cancer mortality is associated with huge productivity loss. As an
illustration, after adjusting for age group and sex, average medical expenditures
among people diagnosed with diabetes were about 2.3 times higher than
expenditures for people without diabetes (American Diabetes Association). In 2017,
the total direct and indirect estimated cost of those diagnosed with diabetes in the
US was about $327 billion including $237 billion in direct medical costs and $90
billion in reduced productivity (American Diabetes Association, 2018). I am using
sophisticate statistical tool such as logistic regression, Cox proportional hazards
regression, and multinomial logistic regression to analyses the data. In the case of
diabetes, the data was collected from the Texas Behavioral Risk Factor Surveillance
Survey (BRFSS) 2008 − 2013. It is a phone survey that collects state data about
U.S. residents regarding their health-related risk behaviors, chronic health
conditions, and use of preventive service. In my study, I have a large sample size of
9, 805 diabetes patients. For the socio-economic study of breast cancer survival,
data for breast cancer cases was provided by the Texas Cancer Registry (TCR),
Cancer Epidemiology and Surveillance Branch, Texas Department of State Health
Services. It is a retrospective cohort study in Texas and I include only the diagnosis
of breast cancer patients recorded by the SEER Program in 1995 and 1996, and we
follow them up to 2015 with a large sample size of 21, 107 survivors of breast cancer.
My study in diabetes concludes that self-care management and quality of care are
heavily impacted by the race differential in Texas. In fact, 41.4% of Hispanics fail to
perform daily foot care compare to 34.2% of White non-Hispanic and 25% of Black
non-Hispanic. Only 50.98% of Hispanics attended class compare to 57.89% of white
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and 63.55% of Black non-Hispanics. Furthermore, Hispanics are less likely to have a
provider checking their AIC (OR: 0.54, 95%, CI, .45-.63) and Black (OR: 0.87,CI
0.67-1.12) compared to Whites. Hispanics were less likely to get flu shot (OR: .62,
95%, CI,.56-.68), and Black (OR: .64, 95%, .56-.74) compared to White
non-Hispanic. Hispanics were also less likely to get pneumonia shot (OR: .35, 95%,
CI, .32-.38), and Black (OR: .56, 95%, .48 − .64) compared to White non-Hispanic.
However, having health care coverage and taking a diabetes self-management course
are contributing factors to the reduction of racial disparity in self-care management.
From my research on breast cancer, I find that stage at diagnostic is the most
important drivers of breast cancer survival, in fact, Compared to stage1 survivors,
survivors with stage IV are more likely to die with a hazard ratio of (14.02). My
findings also suggest that most of the disparities in terms of stage, grade, age, race
and income occur in the first five year of survival. I conclude that Policy makers
need to promote early screening and diagnostic in vulnerable communities.
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Chapter 2
Racial differences and impact of
health care coverage in self-care
management and quality of care on
diabetes in Texas

2.1

Introduction

Diabetes is a chronic disease that can lead to serious complications if not
properly taken care of. An estimate of 9.4% of the United State (US) population
(30.3 million people) had the disease in 2015, according to the National Diabetes
Statistics Report. Additionally, an estimate of 33.9% of the US adults aged 18 years
or older (84.1 million people) had prediabetes in 2015. Prediabetes is a condition
that can lead to type 2 diabetes if there is no significant change toward a healthier
lifestyle. In 2014, 7.2 million hospital discharges and 14.2 million emergency
department visits were reported with a diabetes diagnosis among US adults aged 18
years or older. After adjusting for age group and sex, average medical expenditures
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among people diagnosed with diabetes were about 2.3 times higher than
expenditures for people without diabetes (American Diabetes Association); in 2012,
the total direct and indirect estimated cost of those diagnosed with diabetes in the
US was about $245 billion, including $176 billion in direct medical costs and $69
billion in reduced productivity and total direct and indirect cost rise to $327 billion
in 2017 including $237 billion in direct medical costs and $90 billion in reduced
productivity(American Diabetes Association, 2018), and this constitutes a burden
to tax payers. Complications due to diabetes, such as cardiovascular diseases and
kidney failure are very costly. Also, in 2015, diabetes was the seventh leading cause
of death in Texas and in the US, according to Center of Disease Control and
Prevention (CDC). Therefore, self-management and quality of care for diabetes
patients are extremely crucial to avoid further health complications and reduce
morbidity, mortality, and medical cost significantly. The southern states,
specifically, have the highest incidence and prevalence of the disease. In my study, I
focus on Texas, where diabetes is a growing epidemic that affects 11.2% of the
population, according to the CDC, and diabetes in Texas is taking a drastic
physical and financial toll on the state. In fact, in 2017, the total diabetes cost was
about 25.60 billion in Texas. It is a public health concerns that include the region of
the Rio Grande Valley where 26% of the population suffers from diabetes and the
incident of prediabetes is still growing. The literature suggests that there might be
some racial disparities in self-management and quality of care in diabetes patients in
the past (Sloan, Padroťn, and Platt (2009); Nwasuruba, Osuagwu, Bae, Singh, and
Egede (2007); Adams, Zhang et al. (2005)). My contribution to the literature on
diabetes is to investigate if there is a racial difference in self-management and
quality of care on diabetes patients from 2008-2013 in Texas. In addition, this paper
seeks to understand how having health care coverage and taking a diabetes class
will impact self-management and quality of care in Texas. The methodology I use to
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analyze the data is the multiple logistic regression models. The data was collected
from the Texas Behavioral Risk Factor Surveillance Survey (BRFSS) 2008 -2013.

2.2

Background

Diabetes is a chronic disease that is associated with abnormally high levels of
sugar or glucose in the blood due to the bodiesŠ inability to produce or respond to
the hormone insulin. Type 1, type 2, and gestational diabetes are the most common
types of diabetes. Type 1 diabetes is often diagnosed in children and young adults,
although it can appear at any age. People with this type will need to take insulin
every day to stay alive, and it accounts for less than 5% of all diagnostic diabetes in
the US (CDC). Improving glycemic control in patients with type 1 diabetes
substantially reduces their risk of microvascular complications and cardiovascular
disease, according to Lind, Svensson et al. (2014). Type 2 diabetes is mostly
diagnosed in middle-age and older people, yet it can occur at any age. In type 2, the
body does not produce or use insulin well, and between 90 − 95% of all diagnosed
with diabetes have type 2. Gestational diabetes can develop during pregnancy in
some women. In most cases, this type goes away after women give birth, yet
according to Kim, Newton and Knopp (2005), it is a risk factor for type 2 diabetes
later in life Finally, in cost benefit analyze we can observe that it is much cheaper to
take the diabetes self-care management class and have access to the quality of care
than pay for the complications. The table below 2.1 is showing those costs.
Therefore, it is extremely urgent to find solutions of avoiding costly complications
due to diabetes for taxes payers, patients and insurance companies.
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Table 2.1: Cost analysis for people living with diabetes in the USA
Average Cost

Individual Diabetes
Self-Management, Initial Visit per hour

$20 − $182.00

Individual Diabetes
Self -Management,
Follow Up Per hour

$20 − $91.00

Cost for flu shot

$15 − $40 with no insurance

Cost for pneumonia shot

$125.99 − $229.99(ex: Pneumovax 23)

Group Diabetes Management
Two-Hour Class Sessions

$20 − $140.00

Gym membership
per month

$10 − $20.00

Doctor visit

$100 − $400.00

People with diagnosed
diabetes incur average
medical expenditures

The costs of hospitalizations
involving stroke

$16, 750.00, which about$9, 600is
attributed to diabetes, in 2017

average cost is between 20,396 and 23, 256

A foot or leg amputation costs
in initial hospital costs,

2.3

Between $30, 000and$60, 000

Literature Review

Referring to the concept of health capital and the demand for health, Grossman
(1972) constructs a model of the demand for the commodity "good health." To him,
individual demands good health because there is positive utility associated with
being healthy, and having good health determines the amount of time available for
home and income production. In the case of diabetes patients, good health can be
viewed as avoiding further health complications due to the diabetes. Thus, those
patients will get positive utility of being healthy. They would like to be more
productive at home and at work and avoid losing time being hospitalized or sick.
Additionally, the state will save more money if all diabetes patients have good
health. Therefore, I must analyze and control the risk factors that can lead to
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diabetes complications. So, according to the National Health and Nutrition
Examination Survey (NHANES) and National Center for Health Statistics Centers
for Disease Control and Prevention, the main risk factors for complications among
adults aged 18 years or older with diagnosed diabetes in the USA in 2011-2014 are,
obesity, physical inactivity, smoking, high blood pressure, and high blood glucose.
Obesity is the key risk factor for complications in diagnosed diabetes with around
87% of people with the disease in the US being obese or overweight (National
Diabetes statistics Report, 2017). Obese people have added pressure on their body’s
ability to use insulin to accurately control blood sugar levels and are, consequently,
more likely to develop diabetes or have more complications from it. Therefore, good
self-management for diabetes patients will require healthier nutrition and exercise to
reduce the bodyŠs weight. Additionally, salty, fatty, and sweet foods need to be
avoided to prevent future complications, such as cardiovascular disease, kidney
damage, amputations, loss of sight, nerve damage, and depression. For instance, Hu
and Malik (2010) assess risk of obesity and type 2 diabetes due to sugar-sweetened
beverages (SSB). Hu and Malik (2010) review the literature on the impact of SSB
on obesity and diabetes until 2006, and their conclusion is that epidemiological
studies clearly indicate that regular consumption of SSBs can lead to weight gain
and substantially increase risk of developing chronic diseases including MetSyn,
T2DM and CHD. Therefore, self-management for diabetic patients should include
controlling their intake of sugar-sweetened beverages, such as soda.
Furthermore, Chou, Shin-Yi, Mi, Grossman, and Saffer (2004) study the factors
that may be responsible for the 50% increase in the number of obese adults in the
US since the late 1970s. They use the Behavioral Risk Factor Surveillance System
for the years 1984Ű1999 and their findings suggest fast-food and full-service
restaurants as culprits in undesirable weight outcomes. Also, technological
innovations and the realization of economies of scale that led to reductions in the
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fast-food restaurant price may have been stimulated in part by efforts to
accommodate the increased demand for consumption of food away from home.
Therefore, to fight obesity among diabetes patients we need to reeducate them on
staying away from unhealthy food and cooking more for themselves. Likewise,
smoking is a risk factor for complications with diagnosed diabetes. In fact, smoking
increases insulin resistance and is associated with central fat accumulation. As a
result, smoking is surely a risk factor for complications for diabetes patients.
Moreover, smoking increases the risk of metabolic syndrome and diabetes, and these
factors increase risk of cardiovascular disease, which is one of the major
complications that leads diagnosed diabetes patients to be hospitalized, according to
Chiolero et al. (2008) and Attvall et al. (1993). Moreover, blood glucose control is
important for self-management and quality of care for diabetes patients to check the
status of the disease. Therefore, the A1C test is recommended for blood glucose
control. The A1C test is a blood test that provides information about a personŠs
average levels of blood glucose, also called blood sugar, over the past 3 months. The
A1C test is sometimes called the hemoglobin A1C, HbA1c, or glycohemoglobin test.
The A1C test is the primary test used for diabetes management and diabetes
research. Below 5.7% is normal, between 5.7% and 6.4% the person is considered to
suffer from prediabetes, and above 6.5% is considered as diabetic (National institute
of Diabetes and Digestive and Kidney Disease). Therefore, the American Diabetes
Association recommends people who have the disease to use A1C or any test at
least 2 times a year to control their blood glucose. Shah, Langenberget al.(2015)
studied a cohort of 1, 921, 260 individuals in England, of whom 1, 887, 062 (98.2%)
did not have diabetes and 34, 198 (1.8%) had type 2 diabetes. Their goal was to
assess the incidence of cardiovascular diseases and type 2 diabetes. From a follow up
of 5.5 years, they found that 6, 137 (17.9%) of type 2 diabetes patients have
cardiovascular disease and the most common were peripheral arterial disease, heart
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failure, ischaemic stroke, stable angina, and non-fatal myocardial infarction.
Furthermore, they find that for individuals aged 40 years old without cardiovascular
disease, the overall estimated risk of developing any cardiovascular disease by age 80
years was 30.7% (95% CI 30.3 − 31.0) for women without diabetes and 44.3%
(43.8 − 44.7) for men without diabetes, compared to 58.2% (54.9 − 61.4) for women
with type 2 diabetes and 67.4% (64.4 − 70.4) for men with type 2 diabetes.
Therefore, diabetes and cardiovascular diseases are highly correlated. This is very
worrisome when we are aware that cardiovascular diseases are the first leading cause
of death in Texas and in the US.
Therefore, self-management and access to quality of care are vital for diabetes
patients to avoid or minimize the risk of cardiovascular disease, heart failure, and
stoke. Those complications are very debilitating and very costly for individuals who
have it. Also, Kate, Sobel et al (1999) conducted a randomized trial to study if a
chronic disease self-management program can improve health status while reducing
hospitalization. Their study was a six-month randomized, controlled trial at
community-based sites comparing treatment subjects with wait-list control subjects.
Participants were 952 patients, 40 years of age or older with a physician-confirmed
diagnosis of heart disease, lung disease, stroke, or arthritis. They measured health
status, health behaviors and health service utilization, as determined by mailed,
self-administered questionnaires. They found that treatment subjects, when
compared with control subjects, demonstrated improvements with 6 months of
weekly minutes of exercise, frequency of cognitive symptom management,
communication with physicians, self-reported health, health distress, fatigue,
disability, and social/role activities limitations. They also had fewer hospitalizations
and fewer days in the hospital. Yet, no differences were found in pain/physical
discomfort, shortness of breath, or psychological well-being. This paper reinforces
the importance of self-management and quality of care for diabetic patients to avoid
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complications and reduce mortality due to the diseases. Furthermore, this paper
supports my idea that perhaps if all diabetes patients have access to health care
coverage and classes on how to manage it, their condition may improve.
Texas is unique as far as race and ethnicity are concerned. Indeed, it is very
racially and ethnically diverse with more than 40% Hispanics, 12% Black and 40%
White non-Hispanics; based on the literature, racial and ethnic disparities persist
for access to medical care in significant measure for several disease categories and
service types, according to Mayberry et al.(2000). Egede Le and Zheng D (2003)
studied racial/ethnic differences in adult vaccination among individuals with
diabetes with a main goal of examining whether differences in access to health care,
health coverage, and socioeconomic status explained racial differences in influenza
and pneumococcal vaccination rates in individuals with diabetes. They found that
indeed, racial disparity in vaccination rates for adults with diabetes is independent
of access to care, health care coverage, and socioeconomic status. If those
conclusions are accurate, then perhaps having health care coverage may not have
any significant impact on race disparities in terms of self-management for diabetes
patients. State leaders may need to find better approaches that reduce race
disparity and have more significant impacts on improving self-management and
quality of care for diabetes patients. Karter, Moffet et al.(2002) also studied
ethnical Disparities in Diabetic Complications in an Insured Population. Using a
longitudinal observational study conducted from January 1, 1995 to December 31,
1998 in California, they had a total sample of 62, 432 diabetic patients which was
composed of 64% white, 14% black, 12% Asian and 10% Latino participants. Their
study concluded that for end-stage renal disease, there was an elevated incident
among ethnic minorities despite uniform medical care coverage. Furthermore,
Karter, Moffet et al. provided new evidence that rates of other complications are
similar or lower relative to those of whites. According to their studies, genetic origin
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or unmeasured environmental factors or a combination of both can explain those
ethnical disparities. In my paper, I want to investigate if there is a racial disparity
in self-management care for diabetic patients in Texas and if those disparities
persist over time.
In addition, Sloan, Padroťn, and Platt (2009) study preferences, beliefs, and
self-management of Diabetes, they conclude that individualsŠ beliefs about control
over life events and longevity matter to both investments in care and subjective
measures of health outcomes. While such beliefs were associated with self-assessed
outcomes, they were not able to establish a link between these beliefs and the most
widely used single objective measure of diabetes outcomes. Even after controlling
for differences in preferences and beliefs, clinical, cognitive, and demographic
factors, substantial differences in health outcomes, both subjectively and objectively
measured, but not in health investment, by race and ethnicity remained. This
implies that blacks and Hispanics may realize lower returns on health investments,
at least for diabetes care, than do non-Hispanic whites, even after controlling for
socioeconomic factors, cognitive status, and preferences and beliefs. I investigate if
there is a racial disparity in Texas on self-management and quality of care for
diabetes patients. One of the prime conditions for a diabetes patient to successfully
self-manage their condition is to take a diabetes self-management education. In fact,
diabetes self-management education offers a valuable opportunity for individuals
living with diabetes to gain the knowledge, skills, and motivation to successfully
cope with their disease and reduce costly complications. This will then lead to
reduced racial disparity if it exists.
The motivation for this paper also comes from Sloan, Padroťn, and Platt (2009)
and Nwasuruba, Osuagwu, Bae, Singh, and Egede (2007), who also studied racial
differences in diabetes self-management behaviors and quality of care in Texas.
Nwasuruba and al (2007) study was conducted among 1, 720 adults with diabetes
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from 2002 − 2004 in Texas, Behavioral Risk Factor Surveillance Survey. They used a
multiple logistic regression models, and their paper concluded that Hispanics have
poorer access to care and poorer health status compared to whites or blacks. I
contribute to the literature in many ways. In fact, I use recent data from
2008 − 2013. I pool data for the 6-year period, which allows me to have a bigger
sample size of 9, 805, and more importantly to better help to answer the questions I
have raised. Additionally, I am accessing the importance of race on self-management
and quality of care for diabetes patients mainly because the literature has mixed
results on these issues. One the one hand, Nwasuruba et al. (2007) found that there
was a racial disparity in quality of diabetes care, while Brown et al. (2005)
concluded that minority race/ethnicity was not consistently associated with worse
processes or outcomes, and not all differences favored whites. The only notable
socioeconomic position disparity in their study was in rates of dilated eye
examinations. Social disparities in health may be reduced in managed-care settings.
I believe that by identifying the sub groups that are struggling to improve
self-management or have less access to quality of care, I can better assist them and
make resourceful recommendations to state leaders and public health officials.
Furthermore, my study helps understand how having health care coverage and
taking diabetes management classes will impact self-management and quality of
care in Texas. I expect that having health care coverage and a class will be the
solution to improving diabetes self-management and quality of care. Consequently,
it can lead to the elimination of racial disparities among diabetes patients in Texas.
In fact, Lillie-Blanton, and Hoffman (2005) studied the role of health insurance
coverage in reducing racial/ethnic disparities in health care, their paper reviews
evidences from studies specifically designed to quantify the contribution of health
insurance to racial/ethnic disparities in access. They compared measures of access
to health care between whites and a specific racial/ethnic group; measured the
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effects of racial/ethnic differences in social, economic, or health system factors that
may contribute to disparities in access to health care; and quantified the
contribution of racial/ethnic differences in health insurance on disparities in access
to care. They found that health insurance accounts for much of the variation in
racial/ethnic disparities in access to a usual source of care. This paper is relevant
since, health care coverage for patients with diabetes may reduce the racial disparity
in Texas. In addition, I am inspired by the health production function of Frank A.
Sloan and Chee-Ruey Hsieh (2012), Orem‘s self-care deficit nursing theory, and the
clinical guidance of American diabetes Association (ADA) 2018. I then have a
health production function which relates inputs to outputs:

Outputij (H) = fi (self − caremanagmentij , accesstoqualityof careij ,

(2.1)

self − caremanagmentij ∗ accesstoqualityof careij , geneticmakeupij )
Outputij (H) In this case of diabetes, refers to good outcome of diabetes patients
which is to avoid further complications due to the condition such as cardiovascular
disease, amputation, depression. In this case, I use general health reported by the
patients and patients BMI. I consider good outcome as someone reporting having
excellent and good health or someone having a BMI less than 25 (normal weight).
In model (1), i represents individual patient and j represents that individual race/
ethnicity. For race/ ethnicity, I consider Black non-Hispanics, White non-Hispanics,
and Hispanics. Keys assumptions for model (1): Genetic makeup does not vary over
time and is outside the decision maker‘s or diabetes patient control. It is considered
as exogenous to diabetes patients then.
Since, diabetes patients can control their self-care management and access to
quality of care, I consider those variables as endogenous.
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Self-care management and access to quality of care are complement.
Based on Orem‘s self-care deficit nursing theory, I define self-care as a human
regulatory function that persons must perform for themselves to maintain life.
Self-care must be learned, and it must be deliberately performed. As a result,
persons through this self-care management process, exercise intellectual and
practical skills to manage themselves, to sustain the motivation in an effective
manner for essential daily care. The way an individual engages in self-care will vary
due to influences from their culture, environment, and outside influences such as
race and ethnicity. Engaging in self-care and dependent-care are affected by a
personŠs limitations in knowing what to do, when to do it and how to do it. Based
on the American Diabetes Association clinical guidance, for diabetes patients selfcare management is composed by physical activity (Npa ), smoking (Ns ), home
glucose testing (Nhgt ), home foot exam (Nhf e ), and attending diabetes classes (Nadc )
. I will empirically test how each race/ ethnicity performs on each component. The
basic conditioning factors influence both the need and abilities of the person for
performing self-care based on Orem‘s nursing theory. Basic conditioning factors are
factors that affect all persons such as age, gender, developmental state, health state,
health care system, socio-cultural orientation, family system factors, patterns of
living, environmental factors and available resources. In my study, I will check those
demographic characteristics by race. Another input that is central for diabetes
patients is access to quality of care. Based on the ADA guidance, for access to
quality of care I consider AIC test by provider (Zatp ), foot exam by provider (Zf ep ),
dilated eye exam by provider (Zdeep ), received the flu shot (Zrf s ), and received the
pneumonia shot (Zrps ). Finally, self-care management and access to quality of care
are considered complement. Therefore, any diabetes patient who would like to avoid
complications need to perform both. Why fi is important for individual with
diabetes? Based on the index of “quality-adjusted life years” developed by
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Zeckhauser and Shepard (1976) and Weinstein and Stason (1977), I build the
following utility function: Let‘s consider an individual who has diabetes with a
lifetime horizon of T years along which he will enjoy a health status Ht and I
consider that the individual value the quality of life. I assume that each year when
the individual with diabetes avoid complication due to the disease, he can work and
earn income Yt Let‘s the health profile of an individual be

(H1 , t1 , Y1 ; H2 , t2 , Y2 ; · · · ; Hn , tn , Yn )

where health status Ht is maintained for tt periods, income Yt is earned at tt periods
and t1 + t2 + t3 +· · · tn = T I get this utility function:

U (H1 , t1 , Y1 ; H2 , t2 , Y2 ; · · · ; Hn , tn , Yn )

I assume that for the individual with diabetes who value life, there will be some
medical costs or costs related to good self-care management and quality of care such
as health insurance, gym membership. I will denote that cost M I assume that if
the individual with diabetes is very sick, he/she will not be able to work,

Yt = 0

.
The budget constraint will then be:

Yt (Ht ) = qXt + pMt

Where Yt is spent between medical care Mt and other consumption goods Xt at
time t, and p and q being the prices. This budget constraint will be concave rather
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than linear. It is because individual with poor income will not be able to work so
income will be zero. Therefore, for the individual to maximize utility, he/she will
need to conduct an excellent self- care manage of his/her diabetes and have access
to great quality of care. I will then need to analyze all those components by race/
ethnicity to see if there are some disparities. Policy makers should make sure that
diabetes patients have access to good health care coverage and take diabetes
self-care management mainly for the poorest, and sick. In fact, from the budget
constraint I can observe that if you are very sick you cannot work, and if you earn
very low income, you may not be able to sustain medical cost. That is why I will
analyze the race disparity among diabetes patients who have health care coverage
and have taken the diabetes self-care management classes.

2.4

Data Description and Characteristics

I use data from the Texas Behavioral Risk Factor Surveillance Survey (BRFSS)
from 2008 to 2013. It is a phone survey that collects state data about U.S. residents
regarding their health-related risk behaviors, chronic health conditions, and use of
preventive services. Each year, more than 400, 000 adult interviews are collected. It
is a well-recognized tool for health researches in the US and it has been used for
epidemiology, public health, health economist in their research publications. In this
paper, I use data from 2008 to 2013. This approach helps increase the sample size
and allows for subgroup investigation. The BRFSS does not distinguish between
diabetes types 1 and 2, so I will not be able tell the difference either between type 1
and type 2. Yet, I know that less than 5% of all diagnosis diabetes are type 1 and
can then assume most results are for type 2 patients. I exclude gestational diabetes
in my study. I am using a multiple logistic regression model to see the racial
disparity and impact of health care coverage in diabetes self-management and
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quality of care in Texas. In my study, I define race or ethnicity as White
non-Hispanics, Black non-Hispanics, and Hispanics. I create four age categories,
which are 18-34, 35-49, 50-64 and 65 and plus years, and education is categorized as
less than high school graduate, high school graduate, and some college education or
more. Income is categorized as less than $25, 000.00, less than $50, 000.00, and
$50, 000.00 and more. Marital status is dichotomized as married and not married.
Employment is dichotomized as employed and non-employed. Health status is
categorized as excellent, very good, or good vs fair or poor. Body mass index (BMI)
is categorized as less than 25 (normal or underweight), over 25 (overweight and
obese). I report patients who take insulin.
Table 2.2 displays the demographic characteristics of adults with diabetes in
Texas by race from 2008 to 2013, 55.52% of the sample are white non-Hispanic,
10.43% are Black non-Hispanic and 34.04% are Hispanic. I can see that White
non-Hispanics are much older than Black non-Hispanics and Hispanics in fact 57.7%
of White non-Hispanic are over 65 years old compared to 41.05% of black
non-Hispanic and only 39.6% of Hispanic being over 65 years old. On the education
factor, Hispanics are less educated than Black and White non-Hispanic, 48.52%
have no high school diploma compared to 17.06% for black non-Hispanics and only
8.82% for white non-Hispanics. Income disparity is observed, and Hispanics are
poorer than black non-Hispanics and White non-Hispanics. Hispanics are more
likely to report fair or poor health more than Black non-Hispanics and White
non-Hispanics and less likely to have a regular provider. Black non-Hispanics are
less likely to be employed or married and more likely to be overweight and obese
compared to White non-Hispanic and Hispanic.
Self-management for adults with diabetes in Texas Referring to the American
Diabetes Association guidelines of 2017 and past literature such as Nwasuruba et al.
(2009), Chandler and Monnat (2015), I use 5 variables to assess self-management for
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Table 2.2: Demographic characteristics of adults with diabetes in Texas by race
2008 − 2013
N = 9805
Age
18 − 34
35 − 49
50 − 64
65+
Women
Education
<High School
HS GED
Some college+
Income
< 25,000
25,000 to < 50,000
50,000+
Married
Employed
Health status
Exc./V G/G
Fair/ Poor
Has a regular provider
BMI
<25(normal)
>25(Obese and Overweight)
Takes insulin
Yes

NHW
n = 5444

NHB
n = 1023

H
n = 3338

1.24
13.97
27.07
57.7
56.15

2.64
25.7
30.6
41.05
66.86

3.05
28.34
29.02
39.6
64.89

8.82
28.48
62.7

17.06
33.33
49.61

48.52
24
27.47

34.36
29.59
36.04
52.97
35.6

59.59
21.93
18.48
32.31
31.2

66.58
19.41
14
53.81
44.31

57.16
42.84
93.83

46.41
53.59
85.3

37.8
62.2
73.68

16.98
83.02

12.35
87.65

12.77
87.22

25.63

37.6

27.97

Notes: NHW=Non-Hispanic white, NHB=Non-Hispanic Black, H=Hispanic

diabetes patients and 5 variables to assess access of quality of care for diabetes
patients. Therefore, to assess self-management I consider: physical activity (Ypa ),
smoking (Ys ), home glucose testing (Yhgt ), home foot exam (Yhf e ), and attending
diabetes classes (Yadc ) I am using a Chi- square test to test if I reject or not the null
hypothesis I then have for self-care management:

H0 : pW k = pBk = pHk
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Ha : pW k 6= pBk orpBk 6= pHk orpW k 6= pHk
Where k is equal to physical activity, smoking, home glucose testing, home foot
exam, or attending diabetes classes, and for instance when K is physical activity,
pW k means proportion of white that are engaged in physical activity.
Table 2.3: Comparison of diabetes self-management by race/ ethnicity in Texas in %

Home glucose testing
>Once daily (yes)
< once daily or Never (No)
Home foot care
>Once daily
<once daily or Never (No)
Attended diabetes class
Yes
No
Smoking
Yes
No
Physical activity
Yes
No

NHW

NHB

H

63.25
36.75

69.46 65.62
30.54 34.37

P-value
0.068

0
65.8
34.2

75
25

58.6
41.4
0

57.89
42.1

63.55 50.98
36.44 49.02

23.37
76.62

36.32 28.88
63.68 77.12

58.26
41.74

59.77 56.17
40.22 43.83

0

0.062

Notes: NHW=Non-Hispanic white, NHB=Non-Hispanic Black, H=Hispanic

2.3 shows a comparison of diabetes self-management by race/ ethnicity in Texas
from 2008 to 2013. I notice that there is race disparity in self-management. In fact,
Hispanics (34.37%) never perform home glucose testing or perform it less than one a
day compared to Black non-Hispanics (30.54%) and White (36.75%) non-Hispanic.
As far as home foot care is concerned, Hispanics (41.4%) never perform home
glucose testing or perform it less than one time a day, compared to Black (25%) and
white (34.2%) non-Hispanic. Black non-Hispanics (63.55%) attended more diabetes
class compared to 57.89% White non-Hispanics and 50.98% Hispanics. They are
more likely to smoke 36.32% compared to White non-Hispanics (23.37%) and
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Hispanics (28.88%). For physical activities, Black non-Hispanics (59.77%) are more
likely to exercise than White non-Hispanics (58.26%) and Hispanics (56.17%). I can
conclude that for diabetes self-care management, Hispanics are doing slightly worse
than Black and white non-Hispanic. Access to quality of care for adults with
diabetes in Texas 2008-2010
To examine access to quality of care for diabetes patients, I consider: AIC test
by provider (Zatp ), foot exam by provider (Zf ep ) , dilated eye exam by provider
(Zdeep ), received the flu shot (Zrf s ), and received the pneumonia shot (Zrps ). I am
using a Chi- square test to test if I reject or not the null hypothesis I then have for
access to quality of care:

H0 : pW k = pBk = pHk

Ha : pW k 6= pBk orpBk 6= pHk orpW k 6= pHk
Where k is equal to AIC test by provider, foot exam by provider, dilated eye
exam by provider, received the flu shot, or received the pneumonia shot. For
instance, pwk when K is received the pneumonia shot, mean proportion of white
that received the pneumonia shot.
Table 2.4 shows a comparison for access to quality of care for adults with
diabetes in Texas by race. Some race disparity in access to quality of care are
observed with all p-values being less than 0.01. In fact, Hispanic (47.67%) never
have the A1C test by provider or not having it once a year compared to Black
(35.89%) and White (32.84%) non-Hispanic. As far as the foot exam by provider,
Hispanics (38.32%) never have it or having it less than once a year. compared to
Black (15.53%) and white (27.81%) non-Hispanic. In terms of a dilated eye exam by
provider, 33.17% of Hispanics never have it or having it less than once a year
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Table 2.4: Access to quality of care for adults with diabetes in Texas by race
2008 − 2013

AIC test by provider
Yes
NO
Foot exam by provider
Yes
No
Dilated eye exam by provider
Yes
No
flu shot
Yes
No
pneumonia shot
Yes
No

NHW

NHB

H

67.15
32.84

64.11 52.33
35.89 47.67

72.18
27.81

84.47 61.68
15.53 38.32

69.68
30.32

75.37 66.83
24.63 33.17

P-value
0

0

0

0
64.42
35.58

53.8
46.2

47.04
52.96
0

68.95
31.05

44.74 56.18
55.26 43.81

Notes: NHW=Non-Hispanic white, NHB=Non-Hispanic Black, H=Hispanic

compared to 24.63% of Black and 30.32% of white non-Hispanics. Less Hispanic
(47.04%) get the flu shot compared to White non-Hispanics (64.42%) and Black
non-Hispanics (53.8%). Finally, only 56.18% of Hispanics get the pneumonia vaccine
compared to 44.74% of Black non-Hispanics and 68.95% of White non-Hispanics.
Therefore, as far as access to quality of care for adults with diabetes in Texas is
concerned, White non-Hispanics are having better access to quality of care than
Black non-Hispanics and Hispanics.

2.5

Econometrics Model and results

I consider several specifications; each of the specifications is run on self-care
management and on access to quality of care. The first specification consists of
running a logistic regression where the dependent variable Y takes on one or zero, it
takes one if the patient took diabetes classes and zero if not, say, and the
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independent variable is race; I defineπ as the probability that Y takes on one. This
first specification can be written as:
This first specification can be written as:

logit(πi ) = ln(

πi
) = β 0 + β 1 Bli + β 2 HSi
1 − πi

(2.2)

Where i is individual, Bli is equal to one if individual i is black person and zero
if not, and HSi is equal to one if individual i is Hispanic and zero if not, here white
race is the control variable.
Table 2.5: Unadjusted odds Ratio of self-care management, access to quality of care
and health output for diabetes patients in Texas.
BNH
Odd ratio,95% CI,
n= 1023
Physical activity
1.06, (.93-1.22)
Home glucose testing
1.32*, (1.02-1.69)
Home foot care
1.56*, (1.19-2.03)
Attended diabetes class
1.27*, (.99-1.61)
Smoking
1.87*, (1.52-2.3)
A1C test by provider
0.87,(.67-1.12)
Foot exam by provider
2.1*, (1.52-2.88)
Dilated eye exam by provider 1.33*, (1.02-1.73)
Flu Shot
0.64*,(.56-.74)
Pneumonia Shot
o.56*,(.48-.64)
Health Plan
0.38*,(.31-.47)
General Health
0.65*,(.57-.74)
BMI
0.69*,( .56-.84)

H
odd ratio, 95% CI
n=3338
.918*,(.84-1)
1.11, (0.94-1.3)
.74*, (.63-.86)
.76*,(.65-.88)
1.33*,(1.14-1.54)
.54*,(.45-.63)
.62*,(.52-.73)
.88,(0.74-1.03)
0.62*, (.56-.68)
0.35*,(.32-.38)
0.18*, (.16-.21)
0.46*,(.42-.5)
0,72*,( .63-.82)

Notes: ? means significance at 5% level of significance,and NHB=Non-Hispanic Black, H=Hispanic

Table 2.5 shows that there is a race disparity in term of self- care management
and access to quality of care. In fact, Hispanic are less likely to check their feet at
home (Odd Ratio (OR): 0.74, 95%, CI, 0.63 − 0.86)) compared to white. Black
non-Hispanic are likely to smoke (OR: 1.87, 95%, CI, 1.52 − 2.3) compared to White
non-Hispanic and Hispanic (OR: 1.33). Hispanic are less likely to have a provider
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check their AIC (OR:0.54, 95%, CI, .45 − .63) and Black (OR: 0.87) compared to
Whites. Hispanics were less likely to get flu shot (OR: .62, 95%, CI, .56 − .68), and
Black (OR: .64, 95%, .56 − .74) compared to White non-Hispanic. Hispanics were
also less likely to get pneumonia shot (OR:.35, 95%, CI, .32 − .38), and Black
(OR:.56, 95%, .48 − .64) compared to White non-Hispanic. Hispanic are less likely
to report having excellent, very good and good (OR: 0.46, 95%, CI, 0.42 − 0.5)
compared to Black (OR: 0.65, 95%, CI, 0.57 − 0.74), and White non-Hispanic.
The second specification consists of running a logistic regression where the
dependent variable Y takes on one (with π) as probability) or zero, it takes one if
the patient took diabetes classes and zero if not, say, and the independent variable
are race, sex, education, marital status, employment status, age, and Income. This
second specification can be modeled as:

logit(πi ) = β 0 + β 1 Bli + β 2 HSi + β 1 sexi + β 2 HSGi

(2.3)

+β 1 CGi + β 2 M ai + β 1 Epi + β 2 AL49i + β 1 AL64i + β 2 AG65i + β 1 ILi + β 1 IGi
where i is individual i, Bli is equal to one if individual i is black person and zero
if not, and HSi is equal to one if individual i is Hispanic and zero if not, here white
race is the control variable; sexi is equal to one if individual i is a male and zero if
not; HSGi is equal to one if individual i is a high school graduate and zero if not;
CGi is equal to one if individual i is a college graduate and zero if not; M ai is equal
to one if individual i is married and zero if not; Epi is equal to one if individual i is
employed and zero if not; AL49i is equal to one if individual i is between 15 and 49
years old and zero if not; AL64i is equal to one if individual i is between 49 years
old and 64 and zero if not; AL65i is equal to one if individual i is more than 65
years old and zero if not; ILi is equal to one if individual i earns between
$25, 000.00 and $50000 and zero if not; IGi is equal to one if individual i earns more
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than $50, 000.00 and zero if not.
Table 2.6: Adjusted OR of diabetes self-care management and access to quality of
care in Texas controlling for age, income, education, marital status
BNH
H
Physical activity
1.22* 1.25*
Home glucose testing
1.27 0.98
Home foot care
1.67* 0.95
Attended diabetes class 1.45* 0.96
Smoking
1.25 0.8*
A1C test by provider
1.08 0.84
Foot exam by provider 2.48* 0.9
Dilated eye exam
by provider
1.7* 1.3*
Flu Shot
0.8* 0.83*
Pneumonia
0.69* 0.55*

Sex
HG
Col
.79* 1.11 1.54*
1.44* 0.85 0.82
1.15 1.78* 1.8*
1.38* 1.61* 2.01*
1.37* 1.09 0.82*
1.17 1.4* 1.87*
0.86 1.6* 1.67*
1.1
1.08
1.31*

1.26
1
1.45*

Mar
1.06
1.01
1.1
1
0.76
1.1
0.94

Empl
1.17*
0.62*
0.9
0.86
0.97
0.85
0.8*

1.53* 1.14
1.16*
1*
1.56* 0.89*

0.88
0.77
0.46*

Notes: ? means significance at 5% level of significance, NHB=Non-Hispanic Black, H=Hispanic

Table 2.7: Adjusted OR of diabetes self-care management and access to quality of
care in Texas controlling for age, income, education, marital status.

Physical activity
Home glucose testing
Home foot care
Attended diabetes class
Smoking
A1C test by provider
Foot exam by provider
Dilated eye exam by provider
Flu Shot
Pneumonia shot

<50k >50k
1.13* 1.71*
0.93
0.83
0.89
0.87
1.1
1.35*
0.83 0.63*
1.2
1.59*
1.01
1.15
1.15 1.48*
1.17* 1.3*
1.17* 1.13

<49
0.68*
1.06
1.22
2.2
0.87
1.84
1.55
1.44
1.14
1.44

<64
0.62*
1.1
1.31
2.1
0.43*
2.13
1.98*
2.16*
1.82*
2.41*

>65
0.69*
1.14
1.37
1.63
0.13*
1.8
2*
4.05*
2.86*
5.21*

Notes: ? means significance at 5% level of significance

2.6 and 2.7 Indicate that there is a significant difference for self-care
management and access to quality of care of diabetes patients in Texas based on
age, income, education, and marital status. In term of age, I observe that patients
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over 65 except for physical activity are more likely to perform self-care management
successfully than others. They have better access to quality of care compared to the
rest and this may be the fact that in the USA 65-year-old individuals and others
have Medicare. This finding suggests that White non-Hispanics who are getting
diabetes at older age compare to Black non-Hispanics and Hispanics are doing
better in term of self-care management and access to quality of care because they
have Medicare. Therefore, having access to great health care may be the solution to
reduce racial disparity among diabetes patients in Texas, and it will also reduce
considerably the costly complications due to diabetes. Except for physical activities
and foot exam by provider, women are doing much better than men. College
graduate are doing better than people with only high school diploma and much
better than people without high school diploma. Employed people are less likely to
successfully perform self-care management and have lower access to quality of care
compare to non-employed people. I observe those households who make over
$50, 000.00 a year are having a better access to quality of care than the rest. Yet,
even after controlling for those socio-economic factors, racial disparity still exists
mainly for flu shot and pneumonia shot. Another concern of this paper is to
examine how having access to health care and taking diabetes self-management
classes help to reduce race disparity in term of self-care management and access to
quality of care among patients with diabetes in Texas. I then run model (1) we
perform specification 1 on diabetes patients who had diabetes self-care management
classes and access to quality of care. The results are presented in Table 9.
Table 2.8 displays the demographic characteristics of adults with diabetes who
have taken a diabetes self-care management and have access to health care in Texas
by race 2008-2013. It is a similar demographic characteristic than the adults with
diabetes in Texas.
On table 2.9, we observe an improvement of self-care management across all
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Table 2.8: Demographic characteristics of adults with diabetes who have taken a
diabetes self-care management and have access to health care in Texas by race
2008-2013
N = 1592
Age
18-34
35-49
50-64
65+
Women
Education
< High School
HS GED
Some college+
Income
< 25,000
25,000 to < 50,000
50,000+
Married
Employed
Health status
Exc./ VG/ G
Fair/ Poor
Has a regular provider
BMI
<25(normal)
>25(Obese and Overweight)
Takes insulin
Yes

NHW
n = 1007

NHB
H
n = 191 n = 394

1.09
16.48
28.8
53.62
58.29

16.48
24.61
35.6
39.27
66.49

2.03
26.14
29.19
42.64
66.5

6.27
26.86
66.86

8.42
29.47
62.11

36.25
26.73
37.01

29.68
29.11
41.21
56.54
37.81

45.78
30.12
24.1
34.21
31.75

59.09
21.81
19.09
53.94
36.64

57.97
42.03
100

53.16
46.84
100

36.76
63.24
100

17.16
82.83

8.6
91.4

14.28
85.7

31.71

41.36

34.77

Notes:NHW=Non-Hispanic white, NHB=Non-Hispanic Black, H=Hispanic

,
races among diabetes patients who have taken a diabetes self-care management and
have access to health care in Texas from 2008-2013. We will then run the regression
to see if the race disparity disappears or remain for self-care management. 2.10 we
observe a small improvement of access to quality to care across all races among
diabetes patients who have taken a diabetes self-care management and have access
to health care in Texas from 2008-2013. We then run the regression to see if the
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Table 2.9: Comparison of diabetes patients‘ self-management by race/ ethnicity
among diabetes patients who have taken a diabetes self-care management and have
access to health care in Texas from 2008-2013

Home glucose testing
>Once daily (yes)
<once daily or Never (No)
Home foot care
>Once daily
< once daily or Never (No)
Attended diabetes class
Yes
No
Smoking
Yes
No
Physical activity
Yes
No

NHW

NHB

H

69.67
30.33

73.54 74.55
26.45 25.45

P-value
0.152

0.011
67.07
32.93

77.96
22.04

67.1
32.9
0

1
0

1
0

1
0
0.006

20.2
79.8

33.33 29.11
66.66 70.88

61.06
38.94

61.78 61.68
38.22 38.32

0.967

Notes: NHW=Non-Hispanic White, NHB=Non-Hispanic Black, H=Hispanic

race disparity disappears or remain for access to quality of care. This specification
can be written as: Where i is individual i , Bli is equal to one if individual i is black
person and zero if not, and HSi is equal to one if individual i is Hispanic and zero if
not, here white race is the control variable, where The second specification consists
of running a logistic regression where the dependent variable Y takes on one (with π
as probability) or zero, it takes one if the patient took diabetes classes and zero if
not, say, and the independent variable are race, sex, education, marital status,
employment status, age, and Income. This second specification can be modeled as:
where i is individual i, Bli is equal to one if individual i is black person and zero if
not, and HSi is equal to one if individual i is Hispanic and zero if not, here white
race is the control variable; sexi is equal to one if individuali is a male and zero if
not; HSGi is equal to one if individual i is a high school graduate and zero if not;
CGi is equal to one if individual i is a college graduate and zero if not; M ai is equal
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Table 2.10: Comparison of diabetes patients access to quality of care by race/
ethnicity among diabetes patients who have taken a diabetes self-care management
and have access to health care in Texas from 2008-2013

AIC test by provider
Yes
NO
Foot exam by provider
Yes
No
Dilated eye exam by provider
Yes
No
flu shot
Yes
No
pneumonia shot
Yes
No

NHW

NHB

H

74.58
25.42

71.1
28.9

63.49
36.51

P-value
0

0
0.8
19.94

92.35 76.58
7.65 23.42
0.125

74.72
25.28

81.58 76.41
18.42 23.59
0

74.15
25.85

57.75
42.25

67
33

70.93
29.07

56.5
43.5

53.5
46.49

0

Notes: NHW=Non-Hispanic White, NHB=Non-Hispanic Black, H=Hispanic

Table 2.11: Adjusted odds Ratio of self-care management, access to quality of care
and health output controlling diabetes patients who have taken a diabetes self-care
management and have access to health care in Texas from 2008 to 2013.

Physical activity
Home glucose testing
Home foot care
Smoking
A1C test by provider
Foot exam by provider
Dilated eye exam by provider
Flu Shot
Pneumonia Shot
General Health
BMI

BNH
Odd ratio,95% CI
n = 1023
1.06,(.93-1.22)
1.31*,(1.02-1.69)
1.56*,(1.19-2.03)
1.87*, (1.52-2.3)
0.86,(.67-1.12)
2.1*, (1.53-2.92)
1.33*,(1.02-1.74)
0.64*,(.56-.74)
o.56*,(.48-.64)
0.65*, (.57-.74)
0.69*, ( .56-.84)

H
odd ratio, 95% CI
n = 3338
.93,(.85-1.01)
1.22*,(1.04-1.44)
.77*, (.65-.903)
1.32*,(1.14-1.54)
.59*,(.45-.63)
.71*,(.59-.84)
.96,(0.82-1.14)
0.64*, (.58-.70)
0.36*,(.32-.39)
0.46*, (.42-.5)
0,72*, (.63-.82)

Dummy

1.18*(1.06-1.32)
1.85*(1.59-2.14)
1.34*(1.16-1.56)
.86(.71-1.03)
2.13*(1.83-2.49)
2.68*(2.28-3.16)
1.85*(1.59-2.16)
1.72*(1.53-1.93)
1.22*(1.09-1.38)
1.05(.94-1.18)
1(.86-1.17)

Notes: ? means significance at 5% level of significance, NHB=Non-Hispanic Black, H=Hispanic

to one if individual i is married and zero if not; Epi is equal to one if individual i is
employed and zero if not; AL49i is equal to one if individual i is between 15 and 49
years old and zero if not; AL64i is equal to one if individual i is between 49 years
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old and 64 and zero if not; AL65i is equal to one if individual i is more than 65
years old and zero if not; ILi is equal to one if individual i earns between
$25, 000.00 and $50, 000.00 and zero if not; IGi is equal to one if individual i earns
more than $50, 000.00 and zero if not, where
Table 2.12: Adjusted odds Ratio of self-care management, access to quality of care
controlling for diabetes patients who have taken a diabetes self-care management
and have access to health care in Texas from 2008 to 2013.
NHB
Physical activity
1.22*
Home glucose testing
1.21
Home foot care
1.64*
Smoking
1.25
A1C test by provider
1.04
Foot exam by provider
2.45*
Dilated eye exam by provider 1.7*
Flu Shot
0.8*
Pneumonia
0.69*
Shot

H
Dummy
1.26*
1.11
1.03
2.01*
0.96
1.32*
0.8*
0.85
0.87
2.02*
0.96
2.76*
1.35*
1.73*
0.85*
1.69*
0.55*
1.26*

Notes: ? means significance at 5% level of significance, and the dummy is 0(if individual i did not take diabetes classes or has not
access to health care) or 1(if individual i took diabetes classes and has access to health care) NHB=Non-Hispanic Black, H=Hispanic

From table 2.11 and 2.12 we can conclude that: In term of self-care
management, besides smoking, I do observe a reduction of race disparity when I add
the dummy to the regression. Furthermore, all the coefficients attached to the
dummy are significant and positive, this implies that having taken diabetes self-care
management classes and having access to quality of care lead diabetes patients to
conduct a better self-care management. For instance, from table 10 individuals who
have taken diabetes self-care management classes and have access to health are
more likely to conduct home glucose testing compared to others with an odds ratio
(OR) of 1.82. And this odds ratio increases from 1.82 to 2.01 when we control for
socio-economic factors on table 11. As far access to quality of care is concerned, I
still observe some race disparities even though there are some reductions.
Furthermore, all the coefficients attached to the dummy are significant and positive
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which implies that having taken diabetes classes and having access to quality of care
lead to a better access to quality of care for diabetes patients. For instance, from
table 10 individuals who have taken diabetes self-care management class and have
access to health are more likely (OR: 2.68) compared to others to have their Foot
exam by provider. This odds ratio increases from 2.68 to 2.76∗ when we control for
some socio-economic factors on table 11. However, the disparity persists on flu shot
and pneumonia shot. I recommend that flu shot, and pneumonia shot be made more
available to all diabetes patients in Texas, and perhaps made them free for patients
who cannot afford those two shots.

2.6

Discussion and Conclusion

My findings suggest that Hispanics with diabetes in Texas are still struggling to
improve their self-management and access to quality of care compared to Black and
White non-Hispanic. However, having health care coverage and having taken a
diabetes self-management class improves the overall self-management and quality of
care across all races. In terms of self-management, the racial disparity reduces
significantly; this is not the case when it comes to access of quality of care. I
recommend that Texas expands good quality insurance coverage and diabetes
self-management classes to all diabetes patients as soon as they are diagnosed with
the condition, mainly for minorities. This will considerably reduce the racial
disparities and the number of diabetes health complications by enhancing diabetes
patient outcomes. In an economic sense, this will probably be cost effective for the
state and the tax payers in the long-run.
However, this paper has some limitations. In fact, when the BRFSS is
conducting a phone survey, there may be a bias. This implies that respondents can
report good behaviors which may not reflect their actual behaviors. Additionally, I
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would like to be able to incorporate respondentsŠ diet as part of the
self-management. I hope that in the future, the BRFSS will incorporate more
precise questions on individual diets.
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Chapter 3
Socio-economic study of breast
cancer survival using survival
analysis: a 20 years cohort study in
Texas

3.1

Introduction

Based on the Centers of Disease Control and Prevention (CDC) report, breast
cancer is the second most common cancer after skin cancer among women in the
United States across all races and ethnicities. In fact, in 2014, 236, 968 women and
2, 141 men in the United States were diagnosed with breast cancer. Additionally,
41, 211 women and 465 men in the United States died from it (CDC). In the U.S.,
one in eight women will be diagnosed with invasive breast cancer during her lifetime
according to National Cancer Institute. In this study, I focus on the state of Texas,
where the total financial cost of hospitalization due to breast cancer in 2016 was
around 252 million. 13, 183 Texas Medicaid beneficiaries have received acute care
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for breast cancer in the fiscal year 2014 with an average expenditure per beneficiary
of 4, 637.63. In 2015, there were 16, 136 new cases of female breast cancer and, in
the same year, it claimed the life of 2, 849 patients in Texas. It is a burden to tax
payers, a public health issue and cancer mortality is associated with huge
productivity loss. In addition the number of new cases is still increasing every year
and the population is getting older. I take advantage of this 20 years cohort study
of cancer survival data in Texas from the Texas Cancer Registry (TCR), Cancer
Epidemiology and Surveillance Branch, Texas. I include only the diagnosis of breast
cancer patients recorded in 1995 and 1996, and we follow them up to 2015 with a
large sample size of 21, 626 survivors to study the main drivers that can explain why
some breast cancer patients live longer than others. I performed a 2-step survival
analysis on the entire data sample, the first consisted of running a log-rank test, a
survival time regression and then the second is consisting of running Cox
proportional hazards regression . Finally, I conducted a multinomial logistic
regression analysis, I divided the data based on the survival time into 4 groups
where group 1 is composed by survivors who live up to 5 years, group 2 is made by
survivors living between 5 and 14 years after diagnostics. Group 3 is only composed
of survivors who died after 14 years, and finally, group 4 is formed by only survivors
who are still alive after the end of the study in 2015. The incomplete observed
responses are censored and dismissed. All those different techniques help better
understand the main drivers of breast cancer survival and the disparities that may
exist within those variables. Knowing those factors makes it easy to identify the
riskiest survivors of breast cancer, and I am able to make effective and resourceful
recommendations to help new patients have a much longer life. This is a unique
approach and to my best knowledge I am the first one to explore the breast cancer
survival this way. The rest of the paper is organized as follows: a background and a
literature review, then I have a data description and characteristics, econometrics
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model and results, and finally a conclusion.

3.2

Background and Literature review

According to the Centers of Disease Control and Prevention, cancer is a disease
in which cells in the body grow out of control. When cancer starts in the breast, it
is called breast cancer. It can spread outside the breast through blood vessels and
lymph vessels. When breast cancer spreads to other parts of the body, it is said to
have metastasized. The most common kinds of breast cancer are invasive ductal
carcinoma, and Invasive lobular carcinoma. The main risk factors of breast cancer
listed by the CDC, Gull Z, Anwar Z, Sherazi BA (2017), and Kelsey,JL, Horn-Ross,
PL (1993) who identify different risk factors which lead to breast cancer, include
older age, genetic mutations, early menstrual period, late or no pregnancy, starting
menopause after age 55, not being physically active, being overweight or obese after
menopause, having dense breast, using a combination of hormonal therapy, taking
oral contraception‘s, family history of breast cancer, drinking alcohol, smoking,
cigarettes and women from high socioeconomic status . It is, therefore, very difficult
to totally prevent breast cancer. Yet, a mammogram is a screening tool that can be
used by physicians to find breast cancer early, sometimes up to three years before it
manifests the first physical symptoms. A mammogram is an X-ray picture of the
breast. A mammography can also be used as a diagnostic tool to confirm the
presence of breast cancer. However, from information provided by National Cancer
Institute, a mammography is not perfect since errors in diagnostics can happen. In
fact, a mammography can make false positive results mostly for young women and
women with dense breast size. It can also find false negative results that can delay
treatment and lead to a false impression of security for affected women. Finally, the
risk of harm from the radiation exposure from a mammography is low, but repeated
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x-rays have the potential to cause cancer. Cathy J.Bradley, K Robin Yabroff and al.
(2008). Recently, there is a new type of mammogram for breast cancer detection
tomosynthesis called 3 D mammogram. It reduces the need for additional
screenings, and improves detection of breast cancer mainly for dense breast tissue.
In January 2018, Texas required all insurance companies to cover 3 D mammogram
for Texas patients. We need to continue investing in research for better screening
and diagnostic tools in the future which will lead to early detection and reduce
breast cancer mortality. Since breast cancer can be a recurrent or chronic disease,
the main goal for survivors is to maximize their survival time. Therefore, it is
important to understand why some survivors live longer than others. Besides,
cancer mortality is associated with a huge productivity loss, as proven by Cathy
J.Bradley, K Robin Yabroff and al (2008) who study productivity costs of cancer
mortality in the United States: 2000-2020.They developed models using the human
capital approach, which relies on earnings as a measure of productivity, to estimate
the value of productivity loss as a result of cancer mortality. A model that included
costs of care giving and household work were used. The values of forgone earnings
for employed individuals and imputed forgone earnings for informal care giving were
then estimated for the years 2000Ű2020. The annual productivity cost from cancer
mortality in the base model was approximately $115.8 billion in 2000; the projected
value was $147.6 billion for 2020. Including imputed earnings loss due to care giving
and household activity increased the base model total productivity cost to $232.4
billion in 2000 and to $308 billion in 2020. Their paper is useful to our analysis, as
it shows productivity costs and all related costs due to cancer mortality. Therefore,
it is important to understand that the longer cancer survivors live the more it helps
minimize the loss of productivity. Furthermore, considering the lifetime earnings of
women and men in the USA based on their educational attainment, I can observe
that an early death has substantial productivity loss associated with it, see Fig 3.1 a
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and Fig 3.2 for more details. For instance, a woman with a bachelorŠs degree has an
expected lifetime earnings estimate of $1.32 million (in net income) and $1.43
million (in gross income), then, it is extremely important that policy makers take
this into account and have policies that will lead to an extended length of survival
for breast cancer survivors, even if those policies imply spending more money on
medical care and facilitating the access to quality of care for new diagnose breast
cancer patients.

Figure 3.1: Men estimated lifetime earnings by educational attainment (in millions
of dollars)
In addition, there are costs associated with breast cancer survivors, according to
Donatus U. Ekwueme, Justin G. Trogdon, Olga A. Khavjou, Gery P. Guy Jr.
(2016) who study productivity costs associated with breast cancer among survivors
aged 18Ű44. They find that, per capita, younger women with breast cancer had
annual losses of $2, 293 (95% CI=$1, 069, $3, 518) from missed work and $442 (95%
CI=$161, $723) from lack of productivity at home. Total annual breast
cancerŰassociated productivity costs for younger women were $344 million (95%
CI=$154 million, $535 million). Older women with breast cancer had lower per
capita work loss productivity costs of $1, 407 (95% CI=$899, $1, 915) but higher
total work loss productivity costs estimated at $1, 072 million (95% CI=$685
million, $1, 460 million) than younger women. As a result, the benefit of survival
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Figure 3.2: Women estimated lifetime earnings by educational attainment (in
millions of dollars)
exceeds the cost of death in terms of finance, economic, labor productivity.
We also need to mention that most of those women are someone daughters,
mothers, or grandmothers, which implies emotional and social loss as well. In the
case of the premature death of a young mother, for instance, the hiring of a
caregiver to tend to her children can be challenging and costly. In the literature,
personal characteristics such as race, age, lifestyles, physical activities, diet, and
treatment, and stage of detection of the cancer, such as mammography, radiotherapy
or chemotherapy, can explain the survival time for breast cancer patients. Breast
cancer survival and race: Anne McCarthy, Jianing Yang, and Katrina Armstrong
(2015) study an increasing disparity in breast cancer mortality from 1979 to 2010
for African American women aged 20 to 49. They find that disease-specific
mortality rates declined over time for selected conditions, but mortality rates were
persistently higher for black women for breast cancer, cervical cancer, colorectal
cancer, ischemic heart disease, and stroke. The mortality rate ratio increased for
breast cancer across the studyŠs period. The annual mortality rate ratio for black
women compared to white women was 1.36 in 1979 compared to 2.00 in 2010.
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Furthermore, Neal A. Chatterjee, Yulei He, and Nancy L. Keating (2013) assess
a racial difference in breast cancer mortality by stage at diagnosis, since
mammography became available. They calculated adjusted odds of distant (versus
local or regional) tumors for 143, 249 white and 13, 571 black women aged 50 to 69
years, diagnosed with breast cancer between 1982 and 2007. In conclusion, in the
mammography era, racial disparities remain in stage at diagnosis which implies that
early diagnostic is a key to better prognostics in the case of breast cancer.
Finally, J. William Eley, Holly A. Hill, Vivien W Chen et al. (1994) examine the
ability of recognized prognostic factors for breast cancer to account for the observed
poorer survivorship in blacks compared to their white counterparts. Their
multivariable survival models were used to estimate the hazard ratio (relative risk of
mortality) for blacks compared to whites, adjusting for various combinations of
potential explanatory factors. They find that approximately 75% of the racial
difference in survival was explained by the prognostic factors studied.
Socio-demographic variables appeared to act largely through racial differences in
stage at diagnosis, which may be amenable to change through improved access to
and use of screening for black women. Therefore, early screening is vital to improve
survival time of breast cancer patients. In fact, Robert S. Kirsner, Fangchaoet al.
(2010) study earlier stage at diagnosis and improved survival among Medicare
health maintenance organizations (HMO)patients with breast cancer. They used a
linkage of two national databases, the Medicare database from the Centers for
Medicare and Medicaid Services (CMS) and the National Cancer Institute‘s (NCI)
Surveillance, Epidemiology, and End Results (SEER) program database to evaluate
differences in demographic data, stage at diagnosis, and survival in patients with
breast cancers over the period 1985 − 2001. Their results have indicated that
Medicare patients enrolled in HMOs were diagnosed at an earlier stage of diagnosis
than fee for services (FFS) patients. HMO patients diagnosed with breast cancer
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had improved survival rates, and these differences remained even after controlling
for potential confounders. Specifically, breast cancer patients enrolled in HMOs had
9% increased probability of survival (hazard ratio [HR] 0.91, 95% confidence interval
[CI] 0.88 − 0.93) than their counterparts enrolled in FFS. These findings persisted
even when patients had a cancer diagnosis before their breast cancer. These findings
show that improved survivorship among breast cancer patients in HMOs compared
to FFS is likely due to a combination of factors, including but not limited to earlier
stage at the time of diagnosis, which reinforced the idea of early diagnosis is a key
to improving survival time for breast cancer patients. Fiona McKenziea*, Lis
Ellison-Loschmanna and Mona Jeffreysb (2011) who investigate reasons for ethnic
inequalities in breast cancer survival in New Zealand find that inequalities persisted
after adjustment for subtype variables (ER/PR/HER2), while adjusting for access
to care variables (extent/size) eliminated the ethnic inequalities in excess mortality.
They conclude that ethnic disparities in breast cancer survival in New Zealand can
be attributed to deprivation and differential access to health care rather than
differences in breast cancer subtypes. I then control for race and ethnicity in my
study to see if there is any disparity on survival time due to race, given that Texas
is diverse in regard to race and ethnicities.
Age at diagnosis and survival of breast cancer: According to Charles E Phelps in
his book Health Economics (1992) any human being stock of health wears out over
time and this route is call aging, and as the stock of health diminishes enough, we
are losing our capacity to function and finally we are going to die. Therefore, age at
diagnosis is an important factor for breast cancer survivorship. Adami, Malker,
Holmberg, Persson, and Stone (1986) analyzed the relation between age at diagnosis
and relative survival in 57, 068 women in Sweden in whom breast cancer was
diagnosed in 1960 to 1978. Their findings suggest that women who were 45 to 49
years old had the best prognosis, with a relative survival exceeding that of the
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youngest patients. They also find that the relative survival declined noticeably after
the age of 49 mainly in women 50 to 59 and women older than 75. They conclude
that the long-term annual mortality rate due to breast cancer approached 1 to 2
percent at the premenopausal ages but exceeded 5 percent throughout the period of
observation in the oldest age group. Additionally, Candyce H. Kroenke, Bernard
Rosner, Wendy Y. Chen, Ichiro Kawachi, Graham A. Colditz, and Michelle D.
Holmes (2004) studied changes in physical and psychosocial function before and
after breast cancer by age at diagnosis. From a large sample size of 122, 969 women
from the Nurses‘ Health Study (NHS) and NHS 2, ages 29 to 71 years, who
responded to pre- and post-functional status assessments. Among them, 1, 082
women were diagnosed with breast cancer between 1992 and 1997. Functional
status was measured using the Medical Outcomes Study Short Form 36 (SF-36).
Mean change in health-related quality of life (HRQoL) scores was computed across
categories representing the combination of incident breast cancer (yes or no) and
age at diagnosis (40, 41 to 64, or 65 years). They conclude that compared to women
40 years without breast cancer, women with breast cancer experienced significant
functional declines. Young (age 40) women who developed breast cancer
experienced the largest relative declines in HRQoL (as compared to middle-aged
and elderly women) in multiple domains, including physical roles(18.8 v 11.5 and
7.5 points, respectively), bodily pain(9.0 v 2.7 and 2.7 points), social functioning
(11.3 v 4.3 and 4.4 points), and mental health (3.1 v 0.0 and 0.4 points). Much of
the decline in HRQoL among elderly (age 65) women with breast cancer was age
related. In my study, I will then see if age at diagnostic still an important factor of
survival time for breast cancer patients in Texas, and which age ranges are the most
at risk. Furthermore, obesity, smoking and alcohol, and the existence of comorbidity
are also influencing negatively the survival time for breast cancer patients. Obesity
and breast cancer: In terms of obesity, most recent studies agree that obesity is a
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determinant for both getting breast cancer and surviving long from it. In fact,
Maliniak, Patel, McCullough, Campbell, Leach, Gasptur and Gaudet (2017) study
obesity, physical activity, and breast cancer survival among older breast cancer
survivors in the Cancer Prevention Study-II Nutrition Cohort for 5, 254 between
1992 and 2013. They conclude that Higher BMI, pre- or post-diagnosis, was
associated with a higher risk of breast cancer-specific mortality in older patients,
independent of comorbidity and stage at diagnosis. Likewise, Connor et al. (2016)
conducted a study on the relationship between obesity and quality of life (QOL)
among Hispanic and non-Hispanic white breast cancer survivors and
population-based controls from the Long-term Quality of Life Study, a 12- to 15-year
follow-up study of breast cancer cases/survivors and controls from New Mexico
(n = 451). They use Body Mass Index (BMI) as a measure of obesity, and follow-up
interviews were modeled with composite scores for physical and mental health from
the SF-36 Quality of Life Survey. Interaction between ethnicity and BMI and
change in BMI were evaluated. All models were adjusted for age, ethnicity, Charlson
Index, depression, fatigue, and physical activity. They found that baseline obesity
(b = −6.58, p = 0.04) was significantly associated with decreased mental health
among survivors, but not among controls. Obesity at baseline and follow-up was
significantly associated with decreased physical health among survivors (baseline
b = −10.51, p = 0.004; follow-up b = −7.16, p = 0.02) and controls (baseline
b = −11.07, p = 0.001; follow-up b = −5.18, p = 0.04). No significant interactions
between ethnicity and BMI were observed. Smoking and breast cancer: Unhealthy
habits, such as smoking, are a factor for breast cancer survival length. First, not
smoking cigarettes and avoiding exposure to secondhand smoke has multiple health
benefits. Secondly, numerous studies have showed that smoking can lead to early
death among breast cancer survival. For instance, Yoichiro et al. (2015) studied use
a prospective cohort to study smoking and survival after breast cancer diagnosis in
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Japanese women. They followed between January 1997 and December 2007, 941
female patients aged 21 years or over at the Miyagi Cancer Center Hospital
(MCCH) that were newly diagnosed as having breast cancer. They found that only
a limited number of patients with a longer duration of smoking might have a higher
risk of all-cause and breast cancer-specific death by stratification of hormone
receptor status among premenopausal women. It has been suggested that this
potential relationship might be related to the estrogen-like substances in active
tobacco smoke, which can exert estrogenic effects. Therefore, smoking should be
avoided if breast cancer survivors would like to extend their survival time. Alcohol
and breast cancer survival: Evidence for the association between alcohol
consumption with breast cancer survival are conflicting in the literature; excessive
consumption of alcohol beverage can have a negative impact for any one health
mainly in the case of chronic condition such as breast cancer survival. For instance,
Yun-Jiu Gou, Ding-XiongXie, Ke-Hu Yang, Ya-Li Liu, Jian-Hua Zhang, Bin Li,
Xiao-Dong He (2013) conducted a Meta-analysis of Cohort Studies on alcohol
consumption and breast cancer survival. After including 25 cohort studies, they find
that only alcohol consumption of less than 20 g/d was associated with increased
breast cancer mortality, but not with increased breast cancer recurrence. However,
Anne M. Weaver, Susan E. McCann, Jing Nie, Stephen B. Edge, Thomas H.
Nochajski, Marcia Russell, Maurizio Trevisan, and Jo L. Freudenheim (2013)
examined the link between alcohol intake from all sources, assessed by cognitive
lifetime drinking history, and all cause breast cancer mortality among women with
breast cancer (N = 1, 097) who participated in a population-based case-control
study. Weaver et al. concluded that there are no associations between drinking
status or total volume of alcohol intake and breast cancer or causing mortality.
High-intensity alcohol consumption may be associated with decreased survival rates
in postmenopausal women with breast cancer. Co morbidity and breast cancer
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survival: The existence of co morbidity, such as diabetes and asthma, is a factor of
early death due to breast cancer. In fact, Santorelli et al. (2017) study racial
differences in the effects of co morbidity on breast cancer-specific survival. They are
using retrospective cohort study of 68, 090 women 66+ years, who were diagnosed
with stage I − III breast cancer in the United States from 1994 to 2004. Their
findings suggest that diabetes without complications was associated with a
significantly increased hazard for breast cancer-specific death among white breast
cancer patients, and aggressive tumor characteristics explained some of this effect.
Also, hyper tension was associated with an earlier stage of breast cancer diagnosis
for both black and white women (p < 0.01). For black women, hyper tension was
also associated with a less aggressive tumor grade (p = 0.02) and for white women
hyper tension was associated with a less aggressive hormone receptor status
(p < 0.01). Stage and grade at diagnostic and breast cancer survival: the stage and
the grade of the cancer at time of diagnosis play a major role on the length of
survivorship and on the treatment the patient is expected to receive. In fact,
staging is used to evaluate the size of a tumor, whether it has spread and how far it
has spread. Understanding the stage of the cancer helps physicians predict the
possible outcome and layout a treatment plan for each patient. The main method
used for defining the stage of a cancer is the TNM (tumor, nodes, and meta-stasis)
system. The TNM system is often used to categorize cancer into five stages: stage
0, stage 1, stage 2, stage 3 and stage 4. In stage 0 abnormal cells are found in the
lining of the breast duct or in the lobules of the breast. It is a non-invasive. Stage 1
usually means that a cancer is relatively small and contained within the breast.
Stage 2 usually means the cancer has not started to spread into surrounding tissue,
but the tumor is larger than in Stage 1. Sometimes Stage 2 means that cancer cells
have spread into lymph nodes close to the tumor. Usually when the cancer is larger,
and it may have started to spread into surrounding tissues and there are cancer cells
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in the lymph nodes in the area, we call it stage 3. Finally, in stage 4, Cancer has
spread to other parts of the body including bones and organs, such as lungs, brain,
or liver. Therefore, the stage at time of diagnostic is key for survival time. Some
studies have confirmed this. According to the American Cancer Society, the rate of
survival from breast cancer by stage after 5 years from diagnosis is the following:
close to 100% for stage0, 98% for stage1, 93% for stage 2, 72% for stage 3, and then
decrease dramatically for stage 4 since only 23% are likely to survive. We need to
diagnose the tumor at the early stage if we aim to improve the survival time for
breast cancer patients. I control for stage at diagnostic in this study.
Beside the stage of the tumor, the grade of the tumor is an important factor for
both survival and treatment options. The grade of a tumor indicates what the cells
look like and gives an idea of how quickly the cancer may grow and spread. Tumors
are graded between 1 and 3. Grade 1: the cancer cells look small and uniform like
normal cells and are usually slow-growing compared to other grades of breast
cancer. Grade 2: the cancer cells are slightly bigger than normal cells, varying in
shape and are growing faster than normal cells. Grade 3: the cancer cells look
different than normal cells and are usually faster-growing than normal cells.
Neighborhood poverty level and breast cancer survival: Access to quality care is
crucial for breast cancer prognostics. Since there is some cost associated with taking
good care of survivors, cost of healthy food, need to maintain physical activity such
as going to the gym, have access to yoga studios. As a result, financial status plays
an important role, and to account for it, I control for neighborhood poverty level
based on the census tract of diagnosis address considering that the data does not
provide the survivors income or education level. In fact, from the literature, the
neighborhood poverty level where the survivors live and their length of survival time
correlate. Boscoe et al. (2010) studied 3 million tumors diagnosed between 2005
and 2009 from 16 states plus Los Angeles, and they were assigned 1 of 4 groupings
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based on the poverty rate of the residential census tract at time of diagnosis. The
sex-specific risk ratio of the highest-to-lowest poverty category was measured using
Poisson regression, adjusting for age and race for 39 cancer sites. Boscoe et al.
(2010) finds that there is a negligible relationship between local poverty rate and
cancer incidence overall, but 32 of 39 individual cancer sites show such an
association, with 14 sites associated with higher poverty and 18 sites associated
with lower poverty. This includes 19 sites with stronger evidence of a relationship as
indicated by a monotonic increase or decrease across all 4 poverty categories. The
combined categories of HPV-associated and tobacco-associated cancers also are
positively associated with poverty. I need to mention that breast cancer incidence
rate is higher among women with high standards of living due to their lifestyles such
as getting married at an older age or not getting married at all, having baby after
30 years old, not breastfeeding and perhaps this high incidence can be explain by
Charles E Phelps hypothesis of “life in a fast Lane”. This hypothesis suggests that
an increase in people incomes comes at the expense of health hazardous industrial
processes which cause a decline in health status. I also look at where the survivors
live such as metropolitan, urban, or rural areas since that can impact what types of
care the survivors receives. For instance, there are more cancer hospitals in big
cities than in rural areas and healthier food stores in cities than in rural areas. All
these factors can have a significant impact on breast cancer patients’ prognostic.

3.3

Data Description and Characteristics

This is a retrospective cohort study in Texas. Data for breast cancer cases was
provided by the Texas Cancer Registry (TCR), Cancer Epidemiology and
Surveillance Branch, Texas Department of State Health Services,1100 West 49th
Street, Austin, TX 78756, https://www.dshs.texas.gox/tcr/. Since November 2017,
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this data has been submitted to the National Program of Cancer Registries (NACR)
and North American National Association of Central Cancer Registries (NAACCR).
This data contains cases of incidence from 1995 up to 2015. TCR reported a total of
2, 083, 875 incidence files of Texas residents with malignant and in-situ cancers from
1995 − 2015. TCR is part of the National Cancer InstituteŠs Surveillance
Epidemiology and End Results (SEER), which holds high quality information on
cancer. I include only the diagnosis of breast cancer patients recorded by the SEER
Program in 1995 and 1996, and we follow them up to 2015. The Texas Cancer
Registry program recorded 15, 968 cases of breast cancer in white non-Hispanics
women and 2, 223 cases of breast cancer in black non-Hispanics women diagnosed,
3, 204 Hispanics and 231 others. In this data, 99.40% are women. I then use the
length of survival for each patient which is by months. I perform 2 types of
analyses. In Texas, the total population in 1995 was 18, 723, 991 where 58.59% are
White non-Hispanics, 27.37% are Hispanics, 11.67% are Black non-Hispanics and
2.36% are others. Additionally, 50.52% are female and 49.48% are male. First, I use
a survival analysis on length of survival to deeply understand the correlation
between survival length and some variables such as race, age, stage, grade, and
poverty level of the survivors. In table 1 below I despite the data descriptive and
characteristics of breast cancer survivors diagnose in 1995 and 1996 in Texas and
since 99% of breast cancer patients are female, I will provide a data descriptive of
female in Texas in 1995 by race and age.
From 3.1, I notice that White non-Hispanics are much older (46.76% are 65 and
older), than Black non-Hispanics (33.88% are 65 and older), than Hispanics (31.4%
are 65 and older), and other are much younger since only 15.56% of them are 65 and
older. This age gap alone can explain survival length disparities among racial
groups. In fact, a 70 year old woman may not have the same survival time than a 45
year old woman. Beside, from the general population in Texas in 1995, I remark
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Table 3.1: Data descriptive and characteristics of Breast cancer survivors diagnose
in 1995 and 1996 in Texas
Variables
Race
White
non-Hispanic
Black
non-Hispanic
Hispanic
Other
Age
0 and 39
40 and 49
50 and 64
65 and 74
Over 75
Gender
Female
Male
Treatment
Chemo and
Radiation
Chemo only
Radiation only
Grade
Grade I
Grade II
Grade III
Grade IV
Unknow grade
Stage
Stage I
Stage II
Stage III
Stage IV
Unknown or
un-staged
Poverty level
0 − 5%
5% − 10%
10% − 20%
20% − 100%
Areas where
survivors lived
Metropolitan areas
Urban areas
Rural areas

n

NHW

FwTx

15573

15573

5572421

2134
3150
225

NHB

FBTx

2134

1121795

H

FHTx

3150

2544590

Other

FOTx

225

220657
67.21%
16.68%
10.83%
3.43%
1.85%

1626
3938
6507
4859
4177

5.81%
16.77%
30.66%
24.68%
22.08%

55.89%
14.72%
14.23%
7.86%
7.3%

13.12%
23.29%
29.71%
18.56%
15.32%

67.67%
13.04%
10.24%
4.87%
4.18%

12.98%
23.37%
32.25%
18.67%
12.73%

73.21%
11.21%
8.97%
4%
2.61%

12.44%
38.22%
33.78%
12%
3.56%

20982
125

99.41%
0.59%

100%

99.25%
0.75%

100%

99.62%
0.38%

100%

97.78%
2.22%

3136
16231
179

16.33%
82.67%
1%

14.83%
84.67%
0.5%

15.39%
83.83%
0.77%

18.31%
80.75%
0.94%

2545
6495
62271
420
5376

13.59%
32.74%
27.34%
1.65%
24.68%

8.06%
24.65%
38.75%
3.09%
25.45%

7.56%
25.33%
34.95%
2.89%
29.27%

7.56%
29.78%
34.22%
2.67%
25.78%

11307
5440
803
1312

56.82%
24.15%
3.44%
5.35%

44.05%
29.29%
4.97%
9.98%

44.32%
31.4%
4.7%
8.1%

49.78%
26.22%
5.78%
4.44%

2245

10.24%

11.72%

11.49%

13.78%

3832
4811
7172
5279

22%
26.73%
36.1%
15.17%

6%
10.36%
28.88%
54.76%

6.48%
11.65%
27.43%
54.44%

30.67%
25.33%
29.78%
14.22%

17375
3396
335

80.5%
17.64%
1.86%

88.66%
10.36%
0.98%

85.87%
13.33%
0.79%

96.89%
3.11%
0%

Notes: Where FWTx means total White non -Hispanic female in Texas in 1995, FBTx means total Black non-Hispanics female in Texas
in 1995, FHTx means total Hispanics female in Texas in 1995 and FOTx means total other female in Texas in 1995.
Source: general population in Texas in 1995 is from the Texas Department of State Health Services
Notes: NHW=Non-Hispanic White, NHB=Non-Hispanic Black, H=Hispanic, Chemo= chemotherapy

that Whites are much older than everyone else. In fact, only 55.89% of White
non-Hispanics are less than 39 years old, while 67.67 of Black non-Hispanics, 67.21%
of other and 73.21% of Hispanics are in that same age group. Moreover, only 1.85%
of others are 75 year old and over while 2.61% of Hispanic, 4.18% of Black

48

non-Hispanics and 7.3% of White non-Hispanics are in this age group. This
disparity in age distribution of female in Texas in 1995 may explain why we have a
racial disparity in getting diagnosed with breast cancer when in the literature we
know that most people get breast cancer after the age of 40 year old. Finally, from
this data 73.86% of all diagnosed in 1995 and 1996 are White non-Hispanics, 10.12%
are Black non-Hispanics, 14.94% are Hispanics and only 1.06% are other races and
ethnicities. Based on grade, White non-Hispanics are being diagnose with early
grade (46.33% are diagnosed with grade 1 and 2) than others (37.34% are diagnosed
with grade 1 and 2), than Hispanics (32.89% are diagnosed with grade 1 and 2) and
then Black (32.71% are diagnosed with grade 1 and 2). From the literature we also
know that being diagnose with early grade and stage yield better prognostic.
Furthermore, White non-Hispanics are being diagnose with early stage (56.82% were
diagnose with stage 1) compared to Black non-Hispanics (44.05% were diagnose
with stage 1), Hispanics (44.32% were diagnose with stage 1) and others (49.78%
were diagnose with stage 1). I observe that White non-Hispanics and other are
living in affluent neighborhood compared to Black non- Hispanics and Hispanics. In
fact, 54.76% of Black non-Hispanics live in a neighborhood where the poverty lane is
over 20% compared to 54.44% for Hispanics, and only 15.17% of White
non-Hispanics and 14.22% of others. Those income discrepancies may play a role on
survival length disparities I perform a log-rank test which is a hypothesis test to
compare distributions of two samples. It is a nonparametric test and appropriate to
use when the data has right censored like in the case of our study. Figure 3.3 shows
the relation between survival probabilities for breast cancer patients with respect to
different stages at diagnostic; from it I observe that the stage at diagnostic
significantly plays a major role on the survival time. For instance, after 5 years of
survival around only 9% of survivors with stage 1 died, however, at the same time
around 80% of survival with stage 4 at diagnostics died. It is then crucial to
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Figure 3.3: Comparing survival by stage
promote and encourage early diagnostic to improve survival time among breast
cancer patients
Figure 3.4 displays the difference in the survival probability of breast cancer
patients among race and ethnicity groups. I notice that there is a significant
disparity of survival probability based on race and ethnicity. For example, after 5
years of survival around 30% of Black-non Hispanics survivors died, around 20% of
Hispanics survivors died, around 15% of White-non Hispanics died and only 5% of
other survivors died. Therefore, it is important to intensify the awareness of breast
cancer within the Black- non Hispanics and Hispanics communities.
Figure 3.5 presents the relation between survival probabilities for breast cancer
patients with regard to different grade at diagnostic, I note that the grade at
diagnostic significantly influences the survival time. For instance, after 5 years of
survival around only 5% of survivors with grade I died, however, at the same time
around 35% of survival with grade 4 at diagnostics died. It is crucial to promote and
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Figure 3.4: Comparing survival by Race and ethnicity
encourage early diagnostic to improve survival time among breast cancer patients.
Figure 3.6 depicts the relation between survival probability from breast cancer
and the survivor‘s neighborhood poverty line; I can see that there is a significant
disparity on the survival time. As an illustration, after 5 years of survival around
only 10% of survivors living a high income neighborhood died, however, at the same
time around 25% of survival from poor neighborhood died. We should then better
assist and help survivors from under- privilege neighborhood to improve their
survival time.
Figure 3.7 portrays the relation between survival probability from breast cancer
and type of treatment received by the survivors; I remark that the type of treatment
has a slight impact on the survival time. For instance, after 5 years of survival
around 25% of survivors who receive chemotherapy died, however, at the same time
around 15% of survival who receive radiation only died. This may be due to the fact
that the type of treatment has a correlation with the stage and grade of the disease;
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Figure 3.5: Comparing survival by grade
therefore, I cannot just suggest that all patients need to receive radiation only.

3.4
3.4.1

Econometrics model and results
Model 1: Survival Time Regression Model

log(si (t)) = β 0 + β 1 Genderi + β 2 Racei + β 3 Agei + β 4 T reatmenti +

β 5 Gradei + β 6 Stagei + β 7 IncomeP roxyi + β 8 GeographicAreasi + i

H0 : βk = 0
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(3.1)

Figure 3.6: Comparing survival by neighborhood poverty line

Ha : βk 6= 0
Where i ∼ N (0, 1), and k = 0, · · · K is the number of explanatory variables and
si (t) represent individual survival time
Table 2: Survival Time Regression
From 3.2, based on the Estimate no interaction terms, the most relevant results
indicate that Blacks have the lowest survival length (−0.37?? ) compared to White,
and others race are living longer (0.57?? ) compared to White. Compared to
survivors diagnostic with grade I, survivors with grade II, III, and IV are living less
long. Compared to the Stage 1 survivors Stage II, III, IV and un-stage survivors are
dying earlier. It is imperative to diagnostic patients with breast cancer in early
stage and grade if we aim to increase substantially the length of survival. Compared
to survivors living in neighborhood poverty line between 20% − 100%, survivors
living in more influent neighborhood live much longer. Moreover, when I Interact
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Figure 3.7: Comparing survival by treatment received
stage and age, age and race, and stage and race I find some significant results. For
instance, being black and being between 40 to 49 year old is not a good prognostic
for a breast cancer survivor in Texas.

3.4.2

Model 2: Cox proportional hazards regression

hi (t) = (δ 1 Genderi +δ 2 Racei +δ 3 Agei +δ 4 T reatmenti +δ 5 Gradei +δ 6 Stagei (3.2)

+δ 7 IncomeP roxyi + δ 8 GeographicAreasi + i )h0 (t)
,

H0 : δj = 0
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Table 3.2: Survival Time Regression
Variables

female
Hispanic
black
other
Between 40 and 49
Between 50 and 64
between 65 and 74
over 75
Chemo and
Radiation
Chemo only
Grade II
Grade III
Grade IV
Unknown
stage 2
stage 3
stage 4
Un-stage 5
0%− < 5%
5%− < 10%
10%− < 20%
Metropolitan area
Urban area
Between 40 and 49 * Black
un-stage*Hispanic
un-stage*Black
Between 40 and 49 * Stage4
Between 50 and 59 * Stage4
Between 65 and 74 * Stage4
over 75 * Stage4
over 75 * Stage5

Estimate without
Estimate with
interaction terms Interaction terms
8.79**
0.26
-0.04
-0.37**
0.57**
0.17
0.07
-0.03
-0.43

8.8**
-0.3
-0.15
-0.33**
0.2
0.26
0.22
0.17
-0.2

-0.33
-0.48**
-0.72**
-1.23**
-1.35**
-0.97**
-1.28**
-2.14**
-3.19**
-1.45**
0.31**
0.3**
0.2**
0.21
0.2

-0.33
-0.5**
-0.72**
-1.23**
-1.34**
-0.96**
-1.3**
-2.1**
-2.78**
-1.2**
0.32**
0.31**
0.21**
0.21
0.21
-0.42**
0.39**
0.37**
-0.47**
-0.53**
-0.74**
-0.41**
-0.58**

Notes:?? means 5% level of statistical significance (p-values are less than 5%), Chemo= chemotherapy

Ha : δj 6= 0
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Where the subscript i on an explanatory variable denotes the value of that
variable for the i th individual, and j = 1, · · · , J where J is the number of
explanatory variables.
Table 3.3: Cox proportional hazards regression model estimate
Estimate
female
0.24
Hispanic
0.03
black
0.29**
other
-0.45**
Between 40 and 49 -0.13**
Between 50 and 64
-0.06
between 65 and 74
-0.01
over 75
0.28**
Chemo
and Radiation
0.14
Chemo only
0.26
Grade II
0.58**
Grade III
0.99**
Grade IV
1.1**
Unknown grade
0.8**
stage 2
1.04**
stage 3
1.72**
stage 4
2.64**
stage 5
1.21**
0%− < 5%
-0.25**
5%− < 10%
-0.24**
10%− < 20%
-0.16**
Metropolitan area
-0.19
Urban area
-0.17

Hazard Ratio
1.27
1.04
1.34
0.63
0.88
0.943
0.99
1.32
1.15
1.3
1.78
2.71
3.02
2.21
2.82
5.6
14.02
3.37
0.78
0.78
0.85
0.83
0.85

Notes: ?? means 5% level of statistical significance (p-values are less than 5%), Chemo= chemotherapy

From table 3.3, I see that compared to whites, blacks present higher hazard ratio
(1.34?? ) which means that blacks has 1.34 times risk of dying compared to whites.
Furthermore, compared to survivors age between 0 and 39, survivors 75 and over
present higher hazard ratio (1.32?? ). Compared to survivors diagnostics with grade
I, survivors with more advanced grade are more likely to died early; For instance
grade IV has a hazard ratio (3.02?? ). Moreover, compared to survivors diagnostics
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with stage 1 breast cancer, survivors with more advanced stage are more likely to
die early; for example, survivors with stage IV have a hazard ratio (14.02?? ) that
means that at any particular time, survivors diagnosed with stage IV have 14.02
time vulnerability of dying compared to those diagnosed with Stage I. We then need
to promote early diagnostics to improve survival length. Compared to survivors
living in a less influent neighborhood, survivors in a more affluent one live much
longer. In fact, survivors living in a 0 − 5% poverty line have a hazard ratio (0.78?? ).
Therefore, based on those regressions, the most significant factor is stage at
diagnostics, then grade, follow by income, then age and finally race. Those findings
suggest that stage is a factor of paramount importance. I then would like to better
understand characteristics of breast cancer survivors in Texas by stage. I then
conducted a Cox proportional hazards regression on survivors that were diagnosed
with stage 1 only.
Table 3.4 describes the characteristics of Breast cancer survivors in Texas by
stage, it indicates that White non-Hispanics and other are diagnose with early stage
cancer than Black-non Hispanics and Hispanics. Therefore, policy makers need to
promote early screening in Black non-Hispanics and Hispanics communities. This
data description also shows that younger survivors are being diagnosed with slightly
later stage cancer. Finally, survivors from affluent neighborhoods are being
diagnosed with early stage compared to others. I will then run a Cox proportional
hazards regression model estimate among survivors diagnostic with stage 1.
Table 5: Cox proportional hazards regression model estimate among survivors
diagnostic with stage 1
Table 3.5 portrays that among survivors diagnostic with stage 1, black
non-Hispanics have a high hazard of dying compared to white non Hispanics of 1.45.
Compared to grade 1, survivors diagnose with more advanced grade are more likely
to die early, as an example the hazard ratio for survivors with stage 1 and grade IV
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Table 3.4: Data descriptive and characteristics of Breast cancer survivors in Texas
by stage

n
Race
White
non-Hispanic
15573
Black
non-Hispanic
2134
Hispanic
3150
Other
225
Age
0 and 39
1626
40 and 49
3938
50 and 64
6507
65 and 74
4859
Over 75
4177
Treatment
Chemo and
Radiation
3136
Chemo only
16231
Radiation only
179
Grade
Grade I
2545
Grade II
6495
Grade III
62271
Grade IV
420
Unknown grade 5376
Poverty level
0 − 5%
3832
5% − 10%
4811
10% − 20%
7172
20% − 100%
5279

Stage 1
n = 11, 307

Stage 2 Stage 3 Stage 4 Un-Stage
n = 5440 n = 803 n = 1312 n = 2245

78.33%

69.21%

66.75%

63.54%

71.27%

8.32%
12.36%
0.99%

11.5%
18.2%
1.09%

13.2%
18.43%
1.62%

16.25%
19.45%
0.76%

11.17%
16.18%
1.39%

6.34%
17%
30.94%
25.04%
20.69%

10%
22.54%
31.32%
20.46%
15.68%

9.96%
20.55%
33.25%
17.93%
18.31%

8.92%
17.84%
32.93%
22%
18.6%

7.48%
17.42%
26.99%
22%
26.46%

16.41%
82.76%
0.83%

16.51%
82.65%
0.83%

17.34%
81.5%
1.16%

15.58%
83.69%
0.72%

12.25%
86.05%
1.7%

17.06%
34.34%
25.27%
1.63%
21.7%

7.33%
32.83%
41.19%
2.74%
15.9%

3.99%
28.27%
50.56%
2.74%
14.45%

3.2%
20.12%
37.04%
2.52%
37.12%

6.37%
14.92%
12.52%
1.43%
64.77%

19.4%
24.11%
33.79%
22.7%

17.77%
21.89%
33.93%
26.41%

15.25%
22.38%
35.5%
26.88%

13.72%
20.73%
33.31%
32.24%

16.54%
19.84%
35.09%
28.53%

is at 3.56. The best prognostic will occur when we can diagnose breast cancer
patients at stage 1 and grade 1. Being diagnosed with stage 1 and living in an
affluent neighborhood will lead to better prognostic.
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Table 3.5: Cox proportional hazards regression model estimate among survivors
diagnostic with stage 1
Estimate
female
0.98
Hispanic
0.15
black
0.38**
other
-0.43
Between 40 and 49
-0.14
Between 50 and 64
-0.14
between 65 and 74
-0.137
over 75
0.19
Chemo and
Radiation
0.29
Chemo only
0.41
Grade II
0.73**
Grade III
1.17**
Grade IV
1.27**
Unknown grade
0.75**
0%− < 5%
-0.26**
5%− < 10%
-0.28**
10%− < 20%
-0.08
Metropolitan area
-0.39
Urban area
-0.34

3.4.3

Hazard Ratio
2.67
1.17
1.45
0.65
0.87
0.87
0.87
1.2
1.33
1.5
2.06
3.2
3.56
2.12
0.77
0.75
0.92
0.68
0.72

Multinomial Logistic Regression:

My next step is to investigate when those disparities occur; is it in the first 5
years of survival or is it later. Therefore, I conducted a multinomial logistic
regression; I create 4 groups of breast cancer survivors, the first group only
comprises of survivors who died between 0 and 5 years after diagnostic of breast
cancer, the second group is made of survivors who died between 5 years and 14
years, the third group is only constituted of survivors who died after 14 years, and
finally the fourth group is formed by only survivors that are still alive after the end
of the study in 2015. The incomplete observed responses are censored and classified
in group 5. For the rest of the study, I focus on the 4 first groups only. I am
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starting this analysis by showing the data descriptive and characteristics of breast
cancer survivors in Texas by groups. Table 6: Data descriptive and characteristics
of Breast cancer survivors in Texas by groups
From Table 3.6 I observe that:
In terms of race, Black non-Hispanic have lower survival rate compared to White
non-Hispanics, Hispanics and others. In fact, 37% of Black non-Hispanics died
within 5 years of diagnostic (group 1) compared to 31.36% of Hispanics, 27% of
White non-Hispanics, and only 13% of others in the same period. Furthermore,
when I consider group 4, which is for survivors who are still alive after 2015, I see
that only 25.3% of Black non-Hispanic are in that group compared to 30% of White
non-Hispanics, 32.7% of Hispanics, and 54.35% of others. Therefore, there is a racial
disparity in term of survival length of breast cancer in Texas.
In terms of age, breast cancer patients that are 75 and older have a lower
survival time compared to survivors that are younger. For instance, 46.07% of
survivors that are 75 and over did not live beyond 5 years of diagnosis compared to
26.12% for survivors who are less than 40 years old. When I consider group 4, only
1.5% of people 75 and over survives compared to 55.27% of survivors that are
between 40 and 49 years old, and 52.11% of people between 0 and 39 year old did
survive. This can be explained by the fact that survivors over 65 have existing
comorbidity compared to the younger survivors and the life expectancy of women in
the USA is at 81.3 years.
In terms of grade and stage, I can notice that as the grade or stage progress, the
survival time reduces. Based on the stage, only 17.13% of all diagnostics with stage
I died within 5 years compared to 78.39% of all diagnostics with stage IV. However,
those 17.13% represented 1, 776 survivors and the 78.39% represent 1, 012 survivors.
Therefore, promoting early diagnostics through better screening strategy is crucial
yet not enough, and we are going to investigate why some survivors diagnosed with
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stage I live only 5 years and others live beyond 20 years. Additionally, 37.1% of
patients who were diagnosed with stage 1are still alive after 2015 compared to only
4.73% patients who were diagnosed with stage IV. Moreover, based on grade,
16.05% of patients diagnosed with grade I died within 5 years compared to 41.8% of
patients diagnosed with grade IV.
In terms of poverty level of where the survivor lives, I can observe that there is a
positive relation between the lower poverty level and the survival length. Indeed,
22.08% of survivors that live in neighborhood where only 5% of the residents live
under the poverty level died within 5 years of diagnosis compared to 35.52% of
people who live in the neighborhood that have more than 20% of their residents
living under the poverty line. This may be explained by the income of the survivor,
and in health economics we know income and access to quality of care are positively
related. Furthermore, this can be explained by the fact that in affluent
neighborhoods, there are better hospitals and amenities like gyms, organic food
stores, and more recreational activities that all contribute to length of survival. In
terms of where the survivor lives, there is some slight disparity since patients living
in metropolitan areas who are living much longer than patients living in rural areas,
which can also be explained by availability of services and hospitals that specialize
on cancer treatments.
Multinomial logistic regression analysis
I model the multinomial logistic regression as follows:
Let Y be a categorical response with 4 categories , that is Y takes 4 values, 1 are
those in group 1, 2 are those in group 2, 3 is for group 3 and 4 are those in group 4;
Let πj (x) = P (Y = j|x) at a fixed setting x for explanatory variables, with
P4

j=1

πi = 1 Logit models pair each response category with a baseline category, here
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I consider group 4 as the baseline category. So, the model is as follows:

log

πj (x)
0
= αj + βj (x)
π4 (x)

, j = 1, 2, 3 With
0

βj = (β1j , β2j · · · βkj )
0

and x = (race, gender, age, treatment, grade, stage, poverty, city)
Table 7: Multinomial logistic Regression on Breast cancer Survival time
Table 3.7 describes the multinomial logistic Regression analysis with group 4 as
the reference category. The most relevant results indicate that for all other
covariates fixed for instance, for stage 3 estimated odds that those whose length of
survival is less than 5 years (group 1) instead of those whose length of survival is
still alive (group 4) are exp (2.34) = 10.42 times the estimated for odds for stage 1,
and this is statistically significant with a p-value < 0.0001; the Wald 95% confidence
interval is (8.28, 13.11).
Furthermore, stage 3 estimated odds for those in group 2 are exp 1.25 = 3.47
times the estimated for odds for stage 1 and it is statistically significant. The odd
estimate decreased in group 3 to exp 0.48 = 1.56. For stage 4, the estimated odds
become exp 3.96 = 52.36 times the estimated odds for stage 1 with a p-value
< 0.001, the Wald 95% confidence interval is (39.75, 68.97), and the odd decreases
to 5.88 in group 2 and to 2.02 in group 3. So, the conclusion is that early diagnosis
is key for longer survival, and the disparities mostly occur in the first 5 years of
survival.
For Black non-Hispanics estimated odds that those whose length of survival is
less than 5 years (group 1) instead of those whose length of survival is still alive
(group 4) are exp 0.53 = 1.62 times the estimated for odds for White non-Hispanics,
and this is statistically significant with a p-value < 0.0001; the Wald 95% confidence
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interval is (1.39, 1.89). Furthermore, Black non-Hispanic estimated odds for those in
group 2 are exp 0.34 = 1.38 times the estimated for odds for White non-Hispanics
and it is statistically significant. The odd estimate decreased in group 3 to
exp 0.15 = 1.2. Therefore, the most racial gap occurs in the first five years of
survival this is very worrisome and implies that the productivity loss due to breast
cancer mortality for black non-Hispanics is too enormous.
For survivors 75 and over estimated odds that those whose length of survival is
less than 5 years (group 1) instead of those whose length of survival is still alive
(group 4) are exp 4.86 = 128.74 times the estimated for odds for survivors less than
39, and this is statistically significant with a p-value < 0.0001; the Wald 95%
confidence interval is (94.62, 175.17). Furthermore survivors 75 and over estimated
odds for those in group 2 are exp 4.75 = 115.4 times the estimated for odds for
survivors less than 39 and it is statistically significant. The odd estimate decreased
in group 3 to exp(4.42) = 83.34. Even for survivors between the age of 65 and 74,
the odd is still high. We need to assist the old survivors to improve their survival
time. Finally, living in affluent neighborhood will lead to better prognostic.

3.5

Conclusion

This study allows us to investigate the main factors that can explain the survival
length of breast cancer patients in Texas from a 20-year retrospective cohort data.
My findings suggest that stage at diagnostic is the most important drivers of breast
cancer survival. In fact, Compared to stage I survivors, survivors with stage IV are
more likely to die with a hazard ratio of (14.02). I also find that being diagnosed
with advanced grade will lead to short survival time. For instance, compared to
survival diagnosed with grade 1, grade IV patients have a hazard ratio of (3.02).
Furthermore, I find that there are some racial disparities in survival time. In fact,
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compared to white non-Hispanics, black non-Hispanics have the shorter length of
survivors with a hazard ratio of (1.34), and being black non-Hispanics and being
between 40 to 49 year old is not a good prognostic for a breast cancer survivor in
Texas. I observe that being compared to survivors between the age of 0 and 39,
survivors 75 and older had a higher hazard of dying with a hazard ratio of 1.32.
Living in affluent neighborhood areas improve survival time. Finally, I find that
most of the disparities in terms of stage, grade, age, race and income occur in the
first five year of survival. Policy makers need to promote early screening and
diagnostic in vulnerable communities such as black non-Hispanics and Hispanics.
They also need to better assist survival over 75 year old and black non-Hispanics
patients between the age of 40 and 49, and the poor to improve survival time, since
survival length has huge socio-economic implications. Yet, this paper has some
limitations, as I believe this study would have been stronger if we had access to more
survivorsŠ characteristics, such as education level, and accurate household income.
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Table 3.6: Data descriptive and characteristics of Breast cancer survivors in Texas
by groups
Group 1
n
5631
14616
27%
2011
37%
2911 31.36%
195
13%

Race
White non-Hispanic
Black non-Hispanic
Hispanic
Other
Age
Between 0 and 39
1493
Between 40 and 49 3550
Between 50 and 64 5942
between 65 and 74
4645
75 and over
4124
Gender
Female
19639
Male
115
Treatment
Chemo and
Radiation
2945
Chemo only
15157
Radiation only
169
Grade
Grade I
2362
Grade II
6035
Grade III
5897
Grade IV
390
Unknown grade
5070
Stage
Stage I
10452
Stage II
5091
Stage III
774
Stage IV
1291
Unknown or
un-staged
2146
Poverty level
0 − 5%
3546
5% − 10%
4484
10% − 20%
6738
20% − 100%
4975
Areas where
survivors lived
Metropolitan areas 16231
Urban areas
3205
Rural areas
317
Notes: st is for survivor time

Group 2 Group 3
5353
2817
28%
15%
25.8%
11.44%
23.32%
12.6%
19%
13.33%

Group 4
5932
30%
25.3%
32.7%
54.35%

26.12%
21.07%
22.53%
27.02%
46.07%

16.28%
15.63%
21.66%
33.89%
41.2%

5.49%
8.03%
14.56%
24.22%
11.23%

52.11%
55.27%
41.25%
14.88%
1.5%

28.49%
30.43%

27.09%
33.04%

14.27%
14.78%

30.14%
21.74%

25.94%
28.38%
31.36%

25.16%
27.25%
26.03%

16.13%
13.93%
15.97%

32.6%
30.43%
26.63%

16.05%
23.18%
34.07%
41.8%
33.17%

31%
29.5%
22.88%
20.51%
27.95%

19.94%
15.66%
11.48%
8.97%
13.65%

33.02%
31.66%
31.57%
28.71%
25.23%

17.13%
31.07%
51.81%
78.39%

28.37%
28.05%
24.93%
13.79%

17.4%
13.08%
7.36%
3.1%

37.1%
27.79%
15.89%
4.73%

39.42%

27.68%

11.09%

21.8%

22.08%
23.8%
29.84%
35.52%

23.32%
27.27%
27.8%
28.78%

13.85%
15.14%
14.94%
12.88%

40.75%
33.78%
27.41%
22.81%

27.6%
32.54%
34.38%

26.61%
29.8%
26.18%
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14.2%
14.41%
16.4%

31.58%
23.24%
23.03%

Table 3.7: Multinomial logistic Regression on Breast cancer Survival time

female
Hispanic
black
other
Between 40 and 49
Between 50 and 64
between 65 and 74
over 75
Chemo and
Radiation
Chemo only
Grade II
Grade III
Grade IV
Unknown
stage 2
stage 3
stage 4
Un-stage
0%− < 5%
5%− < 10%
10%− < 20%
Metropolitan area
Urban area

Group 1
n=5114
-1.99**
-0.08
0.07
0.53**
-0.65**
-0.18
0.36**
1.85**
4.86**

Odds Ratio

Odds Ratio

0.85
1.03
1.62
0.5
0.83
1.43
6.34
128.74

Group 2
n=4909
-1.7**
-0.16
-0.07
0.35**
-0.31
-0.04
0.64**
2.2**
4.75**

-0.02
0.17**
-0.3**
0.31**
0.71**
0.06
1.24**
2.34**
3.96**
1.37**
-0.27**
-0.15**
0.07
-0.09
-0.05

Odds Ratio

0.73
0.91
1.38
0.72
0.96
1.9
9.1
115.4

Group 3
n=2614
-2.43**
-0.05
-0.06
0.14
-0.04
0.38**
1.32**
2.9**
4.42**

1.14
1.38
1.62
2.99
4.44
2.31
3.44
10.42
52.36
3.96
0.54
0.61
0.76
0.79
0.82

0.029
0.22**
-0.04
0.06
0.1
0.11**
0.73**
1.25**
1.78**
0.61**
0.26**
-0.02
0.02
-0.03
0.06

1.32
1.6
1.2
1.32
1.38
1.4
2.07
3.47
5.88
1.84
0.59
0.76
0.8
1
1.1

0.1
0.05
-0.06
0
-0.02
0.12
0.4**
0.48**
0.7**
0.25**
-0.2**
0
0.07
-0.06
-0.02

1.28
1.22
0.99
1.06
1.03
1.2
1.5
1.56
2.02
1.3
0.73
0.9
0.96
0.86
0.9

Notes: ?? means 5% level of statistical significance (p-values are less than 5%), Chemo= chemotherapy
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0.9
0.99
1.2
1
1.46
3.74
18.22
83.34
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